<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Evid Based Complement Alternat Med</journal-id><journal-id journal-id-type="iso-abbrev">Evid Based Complement Alternat Med</journal-id><journal-id journal-id-type="publisher-id">ECAM</journal-id><journal-title-group><journal-title>Evidence-based Complementary and Alternative Medicine : eCAM</journal-title></journal-title-group><issn pub-type="ppub">1741-427X</issn><issn pub-type="epub">1741-4288</issn><publisher><publisher-name>Hindawi Publishing Corporation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">25737736</article-id><article-id pub-id-type="pmc">4337037</article-id><article-id pub-id-type="doi">10.1155/2015/593902</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>Pharmacological Properties of Protocatechuic Acid and Its Potential Roles as Complementary Medicine</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Semaming</surname><given-names>Yoswaris</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Pannengpetch</surname><given-names>Patchareewan</given-names></name><xref ref-type="aff" rid="I3">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Chattipakorn</surname><given-names>Siriporn C.</given-names></name><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref><xref ref-type="aff" rid="I4">
<sup>4</sup>
</xref><xref ref-type="aff" rid="I5">
<sup>5</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3026-718X</contrib-id><name><surname>Chattipakorn</surname><given-names>Nipon</given-names></name><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref><xref ref-type="aff" rid="I5">
<sup>5</sup>
</xref><xref ref-type="aff" rid="I6">
<sup>6</sup>
</xref><xref ref-type="corresp" rid="cor1">
<sup>*</sup>
</xref></contrib></contrib-group><aff id="I1"><sup>1</sup>Veterinary Technology Program, Faculty of Technology, Udon Thani Rajabhat University, Udon Thani 41000, Thailand</aff><aff id="I2"><sup>2</sup>Cardiac Electrophysiology Research and Training Center, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand</aff><aff id="I3"><sup>3</sup>Department of Pharmacology, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand</aff><aff id="I4"><sup>4</sup>Department of Oral Biology and Diagnostic Science, Faculty of Dentistry, Chiang Mai University, Chiang Mai 50200, Thailand</aff><aff id="I5"><sup>5</sup>Center of Excellence in Cardiac Electrophysiology Research, Chiang Mai University, Chiang Mai 50200, Thailand</aff><aff id="I6"><sup>6</sup>Cardiac Electrophysiology Unit, Department of Physiology, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand</aff><author-notes><corresp id="cor1">*Nipon Chattipakorn: <email>nchattip@gmail.com</email></corresp><fn fn-type="other"><p>Academic Editor: Sonia Piacente</p></fn></author-notes><pub-date pub-type="ppub"><year>2015</year></pub-date><pub-date pub-type="epub"><day>9</day><month>2</month><year>2015</year></pub-date><pub-date pub-type="pmc-release"><day>9</day><month>2</month><year>2015</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the
							<pub-date pub-type="epub"/>. --><volume>2015</volume><elocation-id>593902</elocation-id><history><date date-type="received"><day>25</day><month>11</month><year>2014</year></date><date date-type="accepted"><day>19</day><month>1</month><year>2015</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2015 Yoswaris Semaming et al.</copyright-statement><copyright-year>2015</copyright-year><license license-type="open-access"><license-p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>This paper reviews the reported pharmacological properties of protocatechuic acid (PCA, 3,4-dihydroxy benzoic acid), a type of phenolic acid found in many food plants such as olives and white grapes. PCA is a major metabolite of anthocyanin. The pharmacological actions of PCA have been shown to include strong <italic>in vitro</italic> and <italic>in vivo</italic> antioxidant activity. In <italic>in vivo</italic> experiments using rats and mice, PCA has been shown to exert anti-inflammatory as well as antihyperglycemic and antiapoptotic activities. Furthermore, PCA has been shown to inhibit chemical carcinogenesis and exert proapoptotic and antiproliferative effects in different cancerous tissues. Moreover, <italic>in vitro</italic> studies have shown PCA to have antimicrobial activities and also to exert synergistic interaction with some antibiotics against resistant pathogens. This review aims to comprehensively summarize the pharmacological properties of PCA reported to date with an emphasis on its biological properties and mechanisms of action which could be therapeutically useful in a clinical setting.</p></abstract></article-meta></front><body><sec id="sec1"><title>1. Introduction</title><p>Protocatechuic acid (PCA, 3,4-dihydroxybenzoic acid) is a phenolic compound found in many food plants such as<italic> Olea europaea</italic> (olives),<italic> Hibiscus sabdariffa</italic> (roselle),<italic> Eucommia ulmoides</italic> (du-zhong),<italic> Citrus microcarpa</italic> Bunge (calamondin), and<italic> Vitis vinifera</italic> (white wine grapes) [<xref rid="B1" ref-type="bibr">1</xref>&#x02013;<xref rid="B3" ref-type="bibr">3</xref>]. PCA content varies considerably depending on the type of food.</p><p>Recently, several investigations have shown that PCA is a major metabolite of complex polyphenols, especially anthocyanins [<xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B5" ref-type="bibr">5</xref>]. Anthocyanins have been shown to affect a variety of physiological activities which are of great benefit to health, including a reduced risk of cardiovascular diseases. This particular beneficial effect is partly due to the anti-inflammatory properties [<xref rid="B6" ref-type="bibr">6</xref>&#x02013;<xref rid="B8" ref-type="bibr">8</xref>], antioxidant and free radical scavenging activities [<xref rid="B9" ref-type="bibr">9</xref>&#x02013;<xref rid="B12" ref-type="bibr">12</xref>], peroxidation inhibition [<xref rid="B13" ref-type="bibr">13</xref>], and estrogenic/antiestrogenic activity [<xref rid="B14" ref-type="bibr">14</xref>] of PCA. PCA is of particular nutritional interest since it is a main anthocyanin metabolite that can reach tissues in amounts which can exert biological effects on health [<xref rid="B15" ref-type="bibr">15</xref>].<italic> In vivo</italic> studies demonstrated that male balb/cA mice which were fed a standard diet supplemented with PCA for 12 weeks showed increased PCA levels in plasma and tissues such as brain, heart, liver, and kidney [<xref rid="B16" ref-type="bibr">16</xref>]. Moreover, PCA itself has been shown to possess antioxidant properties as well as having other potential health benefits such as anti-inflammatory effects.</p><p>The aim of this review is to comprehensively summarize the pharmacological properties of PCA reported to date including antioxidant, anti-inflammatory, antihyperglycemia, antiapoptosis/proapoptosis, and antimicrobial activities, with an emphasis on the biological properties and mechanisms of action which could be potentially useful in a clinical setting.</p></sec><sec id="sec2"><title>2. Antioxidant Activity of PCA</title><p>Oxidative stress plays a key role in the pathogenesis of degenerative diseases such as cardiovascular diseases, diabetes mellitus, neurodegenerative diseases, cancer, and aging [<xref rid="B17" ref-type="bibr">17</xref>&#x02013;<xref rid="B22" ref-type="bibr">21</xref>]. Mounting evidence from both<italic> in vitro</italic> and<italic> in vivo</italic> studies demonstrates that PCA exerts potent antioxidative effects. In<italic> in vitro</italic> studies, as summarized in <xref ref-type="table" rid="tab1">Table 1</xref>, PCA was shown to have free radical scavenging and antioxidant activities by decreasing lipid peroxidation and increasing the scavenging of hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) and diphenylpicrylhydrazyl (DPPH) [<xref rid="B23" ref-type="bibr">22</xref>]. In J77A.1 macrophage, PCA decreased oxidized low-density lipoprotein levels (LDL), inhibited superoxide (O<sub>2</sub><sup>&#x02022;</sup>) and H<sub>2</sub>O<sub>2</sub> production, and also restored glutathione (GSH) related enzymes via c-Jun N-terminal kinase (JNK) mediated nuclear factor (erythroid-derived 2) like 2 (Nrf2) activation [<xref rid="B24" ref-type="bibr">23</xref>, <xref rid="B25" ref-type="bibr">24</xref>]. PCA also reduced reactive oxygen species (ROS) induced apoptosis by improving mitochondrial function, inhibiting DNA fragmentation in H<sub>2</sub>O<sub>2</sub>-induced oxidative stress in human neuronal cells [<xref rid="B26" ref-type="bibr">25</xref>], preventing lactate dehydrogenase (LDH) release in H<sub>2</sub>O<sub>2</sub>-induced oxidative stress in PC12 cells [<xref rid="B27" ref-type="bibr">26</xref>], and inhibiting intracellular ROS level in BNLCL2 cells [<xref rid="B28" ref-type="bibr">27</xref>].</p><p>Consistent with<italic> in vitro</italic> reports,<italic> in vivo</italic> studies (as summarized in <xref ref-type="table" rid="tab2">Table 2</xref>) also demonstrated that PCA treatment decreased oxidative stress by promoting endogenous antioxidant enzymes in aging rats and also reduced H<sub>2</sub>O<sub>2</sub>-induced oxidative damage in aging mice, thus indicating that PCA could prevent oxidative damage in aging animals [<xref rid="B27" ref-type="bibr">26</xref>, <xref rid="B29" ref-type="bibr">28</xref>]. PCA also decreased advance glycation end products (AGEs) and ROS production in D-galactose-induced ROS and AGEs formation in mice [<xref rid="B30" ref-type="bibr">29</xref>]. In streptozotocin (STZ) induced diabetic rats, PCA was also found to decrease ROS formation in liver, heart, kidney, and brain by restoring endogenous antioxidant enzyme activities [<xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B31" ref-type="bibr">30</xref>]. All of these findings indicated that the PCA possess potential antioxidant activity, suggesting that it could be used as a complementary medication to prevent oxidative damage in various degenerative diseases.</p></sec><sec id="sec3"><title>3. Anti-Inflammatory Activity of PCA</title><p>The inflammatory process is regulated by coordinated activation of both pro- and anti-inflammatory mediators in tissue cells (such as fibroblasts, endothelial cells, tissue macrophages, and mast cells) and also by the recruitment of leucocytes [<xref rid="B32" ref-type="bibr">31</xref>, <xref rid="B33" ref-type="bibr">32</xref>]. Prolonged activation of proinflammatory mediators causes tissue injury and organ dysfunction. As a consequence, chronic inflammation plays a critical role in the pathophysiology of major chronic diseases including obesity, cardiovascular disease, diabetes mellitus, Alzheimer's disease, and many types of cancer [<xref rid="B34" ref-type="bibr">33</xref>, <xref rid="B35" ref-type="bibr">34</xref>]. The mediators, including nitric oxide (NO), lipid mediators, cytokines/chemokines, adhesion molecules, and matrix metalloproteinases (MMPs), are involved in the initiation, maintenance, and resolution of the inflammatory process [<xref rid="B36" ref-type="bibr">35</xref>, <xref rid="B37" ref-type="bibr">36</xref>].</p><p>A summary of<italic> in vitro</italic> studies regarding the effects of PCA on the inflammatory process is shown in <xref ref-type="table" rid="tab3">Table 3</xref>. PCA was shown to suppress tumor necrosis factor alpha (TNF-<italic>&#x003b1;</italic>), interleukin- (IL-) 1<italic>&#x003b2;</italic>, inducible nitric oxide synthase (iNOS), and cyclooxygenase 2 (COX-2) expression via the regulation of the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kB) and mitogen-activated protein kinase (MAPK) activation in lipopolysaccharide- (LPS-) induced RAW 264.7 cell damage [<xref rid="B38" ref-type="bibr">37</xref>]. Moreover, PCA also suppressed vascular cell adhesion protein 1 (VCAM-1) and intercellular adhesion molecule 1 (ICAM-1) mRNA expression in TNF-<italic>&#x003b1;</italic>-induced cellular damage [<xref rid="B39" ref-type="bibr">38</xref>] and inhibited monocyte infiltration [<xref rid="B40" ref-type="bibr">39</xref>].</p><p>Consistent with<italic> in vitro</italic> reports, animal studies (<xref ref-type="table" rid="tab4">Table 4</xref>) demonstrated that PCA strongly inhibited inflammation by inhibiting carrageenan-induced inflammation in mice by decreasing TNF-<italic>&#x003b1;</italic>, IL-1<italic>&#x003b2;</italic>, and prostaglandin E2 (PGE<sub>2</sub>) levels, suppressed iNOS and COX-2 expression in apolipoprotein E (ApoE) deficient mice [<xref rid="B38" ref-type="bibr">37</xref>], prevented LPS-induced sepsis in mice via decreased NO levels and suppressed IL-10 [<xref rid="B41" ref-type="bibr">40</xref>], reduced VCAM-1 and ICAM-1 [<xref rid="B39" ref-type="bibr">38</xref>], and inhibited monocyte/macrophage infiltration in mice [<xref rid="B40" ref-type="bibr">39</xref>]. Moreover, PCA also prevented coagulation and inflammation in STZ-induced diabetic rats by inhibiting the plasma levels of the plasminogen activator inhibitor 1 (PAI-1), antithrombin III (AT-III), protein C, C-reactive protein (CRP), and von Willebrand factor (vWF) and reduced IL-6, TNF-<italic>&#x003b1;</italic>, and monocyte chemoattractant protein-1 (MCP-1) levels in the heart and kidneys [<xref rid="B3" ref-type="bibr">3</xref>]. These findings suggest that the anti-inflammatory effects of PCA might be beneficial in various chronic degenerative diseases in which the inflammatory process plays an important part in the pathogenesis.</p></sec><sec id="sec4"><title>4. Antihyperglycemic Activity of PCA</title><p>Maintenance of glucose homeostasis by strict hormonal control is of the utmost importance to human physiology [<xref rid="B42" ref-type="bibr">41</xref>, <xref rid="B43" ref-type="bibr">42</xref>]. Failure of the control of glucose levels, with defects in both insulin action and insulin secretion, can result in a metabolic syndrome which is a multisymptom disorder of energy homeostasis [<xref rid="B44" ref-type="bibr">43</xref>]. It has been demonstrated that peroxisome proliferator-activated receptor gamma (PPAR<italic>&#x003b3;</italic>) is one of several targets of insulin activity, which regulates the expression and activity of key players in the maintenance of glucose transport machinery efficiency, such as glucose transporter (GLUT) 4 and adiponectin [<xref rid="B45" ref-type="bibr">44</xref>, <xref rid="B46" ref-type="bibr">45</xref>]. In<italic> in vitro</italic> studies, as summarized in <xref ref-type="table" rid="tab5">Table 5</xref>, PCA has been shown to exert an insulin-like activity in oxidized LDL-induced insulin resistance in adipocytes via increased PPAR<italic>&#x003b3;</italic> activation [<xref rid="B46" ref-type="bibr">45</xref>]. Similarly,<italic> in vivo</italic> studies (<xref ref-type="table" rid="tab6">Table 6</xref>) also demonstrated that PCA decreased blood glucose levels in STZ-induced diabetes via restored carbohydrate metabolic enzyme activity, increased plasma insulin level, and normalized the activity of pancreatic islets [<xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B31" ref-type="bibr">30</xref>, <xref rid="B47" ref-type="bibr">46</xref>]. These findings suggest that PCA provides antihyperglycemic effects in addition to its reported antioxidant and anti-inflammatory effects.</p></sec><sec id="sec5"><title>5. Antiapoptosis versus Proapoptotic Activity of PCA</title><p>Polyphenols have been shown to improve cell survival and protect against cytotoxicity by inhibiting apoptosis [<xref rid="B19" ref-type="bibr">18</xref>]. However, they can also induce apoptosis and prevent tumor growth [<xref rid="B48" ref-type="bibr">47</xref>, <xref rid="B49" ref-type="bibr">48</xref>]. These opposite effects are mainly due to its effects on the controlling of the cell redox state. Evidence from<italic> in vitro</italic> studies (<xref ref-type="table" rid="tab7">Table 7</xref>) revealed that PCA has cell-protective effects via increased IkB degradation and subsequent NF-kB activation in TNF-<italic>&#x003b1;</italic>-induced cell death [<xref rid="B50" ref-type="bibr">49</xref>], attenuated changes of the mitochondrial membrane permeability, decreased oxidative stress damage and increased Bcl-2 levels in 1-methyl-4-phenylpyridinium- (MPP<sup>+</sup>-) induced apoptotic cell death [<xref rid="B51" ref-type="bibr">50</xref>], decreased caspase-3 activity in isolated neuronal stem cells (NSCs) [<xref rid="B52" ref-type="bibr">51</xref>], and reduced LDH leakage in H<sub>2</sub>O<sub>2</sub>-induced apoptosis [<xref rid="B53" ref-type="bibr">52</xref>]. In MPP<sup>+</sup>-induced cell death, PCA treatment resulted in a return to normal cellular morphology and normal mitochondria [<xref rid="B54" ref-type="bibr">53</xref>]. Moreover, PCA has been shown to have cell-protective effects via antioxidant and scavenging activities [<xref rid="B55" ref-type="bibr">54</xref>].</p><p>Unlike the cells described in <xref ref-type="table" rid="tab7">Table 7</xref>, evidence from cancer cell studies (<xref ref-type="table" rid="tab8">Table 8</xref>) demonstrated that PCA can induce apoptosis and prevent the growth of tumor cells via causing reduced Bcl-2 protein, increased Bax protein expression in human leukemia (HL-60) cells [<xref rid="B56" ref-type="bibr">55</xref>], via activated JNK/p38 MAPK pathways and Fas/FasL pathways, increased translocation of Bax, and reduced Bcl-2 levels in human gastric adenocarcinoma cells [<xref rid="B57" ref-type="bibr">56</xref>] and via induced JNK and p38 MAPK pathways in HepG2 hepatocellular carcinoma cells [<xref rid="B58" ref-type="bibr">57</xref>]. Moreover, PCA also demonstrated anticancer properties by causing apoptosis or suppressing invasion and metastasis in human breast, lung, liver, cervix and prostate cancer cells [<xref rid="B59" ref-type="bibr">58</xref>]. Consistently, an<italic> in vivo</italic> study (<xref ref-type="table" rid="tab9">Table 9</xref>) also demonstrated that PCA inhibited<italic> N</italic>-nitrosomethylbenzylamine (NMBA) induced esophageal tumorigenesis by its inhibitory effects on genes associated with inflammation in rats [<xref rid="B60" ref-type="bibr">59</xref>].</p></sec><sec id="sec6"><title>6. Antimicrobial Activity of PCA</title><p>
<italic>In vitro</italic> studies (<xref ref-type="table" rid="tab10">Table 10</xref>) demonstrated that PCA has an antimicrobial effect against gram positive and negative bacteria and fungi [<xref rid="B61" ref-type="bibr">60</xref>, <xref rid="B62" ref-type="bibr">61</xref>]. PCA also prevented contamination of meat by<italic> Campylobacter</italic> and aerobes, by decreasing lipid oxidation [<xref rid="B63" ref-type="bibr">62</xref>]. PCA exerted its antibacterial effects due to its ability to inhibit bacterial growth and increase the synergistic effects of antibiotics hence reducing the possibility of resistance to drugs [<xref rid="B64" ref-type="bibr">63</xref>]. These antimicrobial activities of PCA have been proposed as promising applications in both health protection and food preservation in order to avoid food-borne illnesses [<xref rid="B63" ref-type="bibr">62</xref>, <xref rid="B65" ref-type="bibr">64</xref>].</p></sec><sec id="sec7"><title>7. Conclusion</title><p>Growing evidence suggests the significant biological potential of PCA through the modulation of cellular signals involved in the control of oxidative stress and inflammation. Moreover, its antiapoptotic effects in normal cells and proapoptotic effects in cancer cells suggest definite benefits as a potential chemotherapeutic agent. However, much evidence of such properties has been collected from cellular and animal studies, while clinical studies are still lacking. Future clinical studies are needed to warrant the clinical usefulness of the PCA.</p></sec></body><back><ack><title>Acknowledgments</title><p>This work was supported by the Thailand Research Fund RTA5580006 (NC) and BRG5780016 (SC), Chiang Mai University Center of Excellence Award (NC), Udon Thani Rajabhat University Fund (YS), and a NSTDA Research Chair Grant from the National Science and Technology Development Agency (NC).</p></ack><sec sec-type="conflict"><title>Conflict of Interests</title><p>The authors declare that there is no conflict of interests regarding the publication of this paper.</p></sec><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>W.-L.</given-names></name><name><surname>Hsieh</surname><given-names>Y.-J.</given-names></name><name><surname>Chou</surname><given-names>F.-P.</given-names></name><name><surname>Wang</surname><given-names>C.-J.</given-names></name><name><surname>Cheng</surname><given-names>M.-T.</given-names></name><name><surname>Tseng</surname><given-names>T.-H.</given-names></name></person-group><article-title>Hibiscus protocatechuic acid inhibits lipopolysaccharide-induced rat hepatic damage</article-title><source><italic>Archives of Toxicology</italic></source><year>2003</year><volume>77</volume><issue>1</issue><fpage>42</fpage><lpage>47</lpage><pub-id pub-id-type="doi">10.1007/s00204-002-0404-0</pub-id><pub-id pub-id-type="other">2-s2.0-0037220021</pub-id><pub-id pub-id-type="pmid">12491040</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pacheco-Palencia</surname><given-names>L. A.</given-names></name><name><surname>Mertens-Talcott</surname><given-names>S.</given-names></name><name><surname>Talcott</surname><given-names>S. T.</given-names></name></person-group><article-title>Chemical composition, antioxidant properties, and thermal stability of a phytochemical enriched oil from A&#x000e7;ai (<italic>Euterpe oleracea</italic> Mart.)</article-title><source><italic>Journal of Agricultural and Food Chemistry</italic></source><year>2008</year><volume>56</volume><issue>12</issue><fpage>4631</fpage><lpage>4636</lpage><pub-id pub-id-type="doi">10.1021/jf800161u</pub-id><pub-id pub-id-type="other">2-s2.0-47349093995</pub-id><pub-id pub-id-type="pmid">18522407</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>P.</given-names></name><name><surname>Wang</surname><given-names>X. Q.</given-names></name><name><surname>Wang</surname><given-names>H. Z.</given-names></name><name><surname>Wu</surname><given-names>Y. N.</given-names></name></person-group><article-title>High performance liquid chromatographic determination of phenolic acids in fruits and vegetables</article-title><source><italic>Biomedical and Environmental Sciences</italic></source><year>1993</year><volume>6</volume><issue>4</issue><fpage>389</fpage><lpage>398</lpage><pub-id pub-id-type="other">2-s2.0-0027794658</pub-id><pub-id pub-id-type="pmid">8198755</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vitaglione</surname><given-names>P.</given-names></name><name><surname>Donnarumma</surname><given-names>G.</given-names></name><name><surname>Napolitano</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Protocatechuic acid is the major human metabolite of cyanidin-glucosides</article-title><source><italic>Journal of Nutrition</italic></source><year>2007</year><volume>137</volume><issue>9</issue><fpage>2043</fpage><lpage>2048</lpage><pub-id pub-id-type="other">2-s2.0-34548399951</pub-id><pub-id pub-id-type="pmid">17709440</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pimpao</surname><given-names>R. C.</given-names></name><name><surname>Dew</surname><given-names>T.</given-names></name><name><surname>Figueira</surname><given-names>M. E.</given-names></name><etal/></person-group><article-title>Urinary metabolite profiling identifies novel colonic metabolites and conjugates of phenolics in healthy volunteers</article-title><source><italic>Molecular Nutrition &#x00026; Food Research</italic></source><year>2014</year><volume>58</volume><issue>7</issue><fpage>1414</fpage><lpage>1425</lpage><pub-id pub-id-type="doi">10.1002/mnfr.201300822</pub-id><pub-id pub-id-type="pmid">24740799</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonz&#x000e1;lez-Gallego</surname><given-names>J.</given-names></name><name><surname>Garc&#x000ed;a-Mediavilla</surname><given-names>M. V.</given-names></name><name><surname>S&#x000e1;nchez-Campos</surname><given-names>S.</given-names></name><name><surname>Tu&#x000f1;&#x000f3;</surname><given-names>M. J.</given-names></name></person-group><article-title>Fruit polyphenols, immunity and inflammation</article-title><source><italic>British Journal of Nutrition</italic></source><year>2010</year><volume>104</volume><issue>supplement 3</issue><fpage>S15</fpage><lpage>S27</lpage><pub-id pub-id-type="doi">10.1017/s0007114510003910</pub-id><pub-id pub-id-type="other">2-s2.0-78049438719</pub-id><pub-id pub-id-type="pmid">20955647</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Landberg</surname><given-names>R.</given-names></name><name><surname>Sun</surname><given-names>Q.</given-names></name><name><surname>Rimm</surname><given-names>E. B.</given-names></name><etal/></person-group><article-title>Selected dietary flavonoids are associated with markers of inflammation and endothelial dysfunction in U.S. women</article-title><source><italic>The Journal of Nutrition</italic></source><year>2011</year><volume>141</volume><issue>4</issue><fpage>618</fpage><lpage>625</lpage><pub-id pub-id-type="doi">10.3945/jn.110.133843</pub-id><pub-id pub-id-type="other">2-s2.0-79955495572</pub-id><pub-id pub-id-type="pmid">21325476</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rotelli</surname><given-names>A. E.</given-names></name><name><surname>Guardia</surname><given-names>T.</given-names></name><name><surname>Ju&#x000e1;rez</surname><given-names>A. O.</given-names></name><name><surname>de la Rocha</surname><given-names>N. E.</given-names></name><name><surname>Pelzer</surname><given-names>L. E.</given-names></name></person-group><article-title>Comparative study of flavonoids in experimental models of inflammation</article-title><source><italic>Pharmacological Research</italic></source><year>2003</year><volume>48</volume><issue>6</issue><fpage>601</fpage><lpage>606</lpage><pub-id pub-id-type="doi">10.1016/s1043-6618(03)00225-1</pub-id><pub-id pub-id-type="other">2-s2.0-1542607405</pub-id><pub-id pub-id-type="pmid">14527825</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garcia-Alonso</surname><given-names>M.</given-names></name><name><surname>Minihane</surname><given-names>A.-M.</given-names></name><name><surname>Rimbach</surname><given-names>G.</given-names></name><name><surname>Rivas-Gonzalo</surname><given-names>J. C.</given-names></name><name><surname>de Pascual-Teresa</surname><given-names>S.</given-names></name></person-group><article-title>Red wine anthocyanins are rapidly absorbed in humans and affect monocyte chemoattractant protein 1 levels and antioxidant capacity of plasma</article-title><source><italic>The Journal of Nutritional Biochemistry</italic></source><year>2009</year><volume>20</volume><issue>7</issue><fpage>521</fpage><lpage>529</lpage><pub-id pub-id-type="doi">10.1016/j.jnutbio.2008.05.011</pub-id><pub-id pub-id-type="other">2-s2.0-67651030946</pub-id><pub-id pub-id-type="pmid">18789665</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Nair</surname><given-names>M. G.</given-names></name><name><surname>Strasburg</surname><given-names>G. M.</given-names></name><etal/></person-group><article-title>Antioxidant and antiinflammatory activities of anthocyanins and their aglycon, cyanidin, from tart cherries</article-title><source><italic>Journal of Natural Products</italic></source><year>1999</year><volume>62</volume><issue>2</issue><fpage>294</fpage><lpage>296</lpage><pub-id pub-id-type="doi">10.1021/np980501m</pub-id><pub-id pub-id-type="other">2-s2.0-0032986801</pub-id><pub-id pub-id-type="pmid">10075763</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>K&#x000e4;hk&#x000f6;nen</surname><given-names>M. P.</given-names></name><name><surname>Heinonen</surname><given-names>M.</given-names></name></person-group><article-title>Antioxidant activity of anthocyanins and their aglycons</article-title><source><italic>Journal of Agricultural and Food Chemistry</italic></source><year>2003</year><volume>51</volume><issue>3</issue><fpage>628</fpage><lpage>633</lpage><pub-id pub-id-type="doi">10.1021/jf025551i</pub-id><pub-id pub-id-type="other">2-s2.0-0037471583</pub-id><pub-id pub-id-type="pmid">12537433</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsumoto</surname><given-names>H.</given-names></name><name><surname>Nakamura</surname><given-names>Y.</given-names></name><name><surname>Hirayama</surname><given-names>M.</given-names></name><name><surname>Yoshiki</surname><given-names>Y.</given-names></name><name><surname>Okubo</surname><given-names>K.</given-names></name></person-group><article-title>Antioxidant activity of black currant anthocyanin aglycons and their glycosides measured by chemiluminescence in a neutral pH region and in human plasma</article-title><source><italic>Journal of Agricultural and Food Chemistry</italic></source><year>2002</year><volume>50</volume><issue>18</issue><fpage>5034</fpage><lpage>5037</lpage><pub-id pub-id-type="doi">10.1021/jf020292i</pub-id><pub-id pub-id-type="other">2-s2.0-0037189848</pub-id><pub-id pub-id-type="pmid">12188603</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsuda</surname><given-names>T.</given-names></name><name><surname>Shiga</surname><given-names>K.</given-names></name><name><surname>Ohshima</surname><given-names>K.</given-names></name><name><surname>Kawakishi</surname><given-names>S.</given-names></name><name><surname>Osawa</surname><given-names>T.</given-names></name></person-group><article-title>Inhibition of lipid peroxidation and the active oxygen radical scavenging effect of anthocyanin pigments isolated from <italic>Phaseolus vulgaris</italic> L</article-title><source><italic>Biochemical Pharmacology</italic></source><year>1996</year><volume>52</volume><issue>7</issue><fpage>1033</fpage><lpage>1039</lpage><pub-id pub-id-type="doi">10.1016/0006-2952(96)00421-2</pub-id><pub-id pub-id-type="other">2-s2.0-0030580038</pub-id><pub-id pub-id-type="pmid">8831722</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cassidy</surname><given-names>A.</given-names></name><name><surname>de Pascual Teresa</surname><given-names>S.</given-names></name><name><surname>Rimbach</surname><given-names>G.</given-names></name></person-group><article-title>Molecular mechanisms by which dietary isoflavones potentially prevent atherosclerosis</article-title><source><italic>Expert Reviews in Molecular Medicine</italic></source><year>2003</year><volume>5</volume><issue>24</issue><fpage>1</fpage><lpage>15</lpage><pub-id pub-id-type="other">2-s2.0-14744291496</pub-id><pub-id pub-id-type="pmid">14585174</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kay</surname><given-names>C. D.</given-names></name><name><surname>Kroon</surname><given-names>P. A.</given-names></name><name><surname>Cassidy</surname><given-names>A.</given-names></name></person-group><article-title>The bioactivity of dietary anthocyanins is likely to be mediated by their degradation products</article-title><source><italic>Molecular Nutrition and Food Research</italic></source><year>2009</year><volume>53</volume><issue>supplement 1</issue><fpage>S92</fpage><lpage>S101</lpage><pub-id pub-id-type="doi">10.1002/mnfr.200800461</pub-id><pub-id pub-id-type="other">2-s2.0-67649968264</pub-id><pub-id pub-id-type="pmid">19415657</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>C.-Y.</given-names></name><name><surname>Tsai</surname><given-names>S.-J.</given-names></name><name><surname>Huang</surname><given-names>C.-S.</given-names></name><name><surname>Yin</surname><given-names>M.-C.</given-names></name></person-group><article-title>Antiglycative effects of protocatechuic acid in the kidneys of diabetic mice</article-title><source><italic>Journal of Agricultural and Food Chemistry</italic></source><year>2011</year><volume>59</volume><issue>9</issue><fpage>5117</fpage><lpage>5124</lpage><pub-id pub-id-type="other">2-s2.0-79955678091</pub-id><pub-id pub-id-type="doi">10.1021/jf200103f</pub-id><pub-id pub-id-type="pmid">21456600</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moura</surname><given-names>M. B.</given-names></name><name><surname>dos Santos</surname><given-names>L. S.</given-names></name><name><surname>van Houten</surname><given-names>B.</given-names></name></person-group><article-title>Mitochondrial dysfunction in neurodegenerative diseases and cancer</article-title><source><italic>Environmental and Molecular Mutagenesis</italic></source><year>2010</year><volume>51</volume><issue>5</issue><fpage>391</fpage><lpage>405</lpage><pub-id pub-id-type="doi">10.1002/em.20575</pub-id><pub-id pub-id-type="other">2-s2.0-77953500851</pub-id><pub-id pub-id-type="pmid">20544881</pub-id></element-citation></ref><ref id="B19"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Queen</surname><given-names>B. L.</given-names></name><name><surname>Tollefsbol</surname><given-names>T. O.</given-names></name></person-group><article-title>Polyphenols and aging</article-title><source><italic>Current Aging Science</italic></source><year>2010</year><volume>3</volume><issue>1</issue><fpage>34</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.2174/1874609811003010034</pub-id><pub-id pub-id-type="other">2-s2.0-77953762857</pub-id><pub-id pub-id-type="pmid">20298168</pub-id></element-citation></ref><ref id="B20"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patten</surname><given-names>D. A.</given-names></name><name><surname>Germain</surname><given-names>M.</given-names></name><name><surname>Kelly</surname><given-names>M. A.</given-names></name><name><surname>Slack</surname><given-names>R. S.</given-names></name></person-group><article-title>Reactive oxygen species: stuck in the middle of neurodegeneration</article-title><source><italic>Journal of Alzheimer's Disease</italic></source><year>2010</year><volume>20</volume><issue>2</issue><fpage>S357</fpage><lpage>S367</lpage><pub-id pub-id-type="doi">10.3233/jad-2010-100498</pub-id><pub-id pub-id-type="other">2-s2.0-77956216928</pub-id></element-citation></ref><ref id="B21"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaneto</surname><given-names>H.</given-names></name><name><surname>Katakami</surname><given-names>N.</given-names></name><name><surname>Matsuhisa</surname><given-names>M.</given-names></name><name><surname>Matsuoka</surname><given-names>T.-A.</given-names></name></person-group><article-title>Role of reactive oxygen species in the progression of type 2 diabetes and atherosclerosis</article-title><source><italic>Mediators of Inflammation</italic></source><year>2010</year><volume>2010</volume><fpage>11</fpage><pub-id pub-id-type="publisher-id">453892</pub-id><pub-id pub-id-type="doi">10.1155/2010/453892</pub-id><pub-id pub-id-type="other">2-s2.0-77952480033</pub-id></element-citation></ref><ref id="B22"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patten</surname><given-names>D. A.</given-names></name><name><surname>Germain</surname><given-names>M.</given-names></name><name><surname>Kelly</surname><given-names>M. A.</given-names></name><name><surname>Slack</surname><given-names>R. S.</given-names></name></person-group><article-title>Reactive oxygen species: stuck in the middle of neurodegeneration</article-title><source><italic>Journal of Alzheimer's Disease</italic></source><year>2010</year><volume>20</volume><issue>supplement 2</issue><fpage>S357</fpage><lpage>S367</lpage><pub-id pub-id-type="doi">10.3233/jad-2010-100498</pub-id><pub-id pub-id-type="other">2-s2.0-77956216928</pub-id></element-citation></ref><ref id="B23"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sroka</surname><given-names>Z.</given-names></name><name><surname>Cisowski</surname><given-names>W.</given-names></name></person-group><article-title>Hydrogen peroxide scavenging, antioxidant and anti-radical activity of some phenolic acids</article-title><source><italic>Food and Chemical Toxicology</italic></source><year>2003</year><volume>41</volume><issue>6</issue><fpage>753</fpage><lpage>758</lpage><pub-id pub-id-type="doi">10.1016/s0278-6915(02)00329-0</pub-id><pub-id pub-id-type="other">2-s2.0-0038402730</pub-id><pub-id pub-id-type="pmid">12738180</pub-id></element-citation></ref><ref id="B24"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Masella</surname><given-names>R.</given-names></name><name><surname>Var&#x000ec;</surname><given-names>R.</given-names></name><name><surname>D'Archivio</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Extra virgin olive oil biophenols inhibit cell-mediated oxidation of LDL by increasing the mRNA transcription of glutathione-related enzymes</article-title><source><italic>Journal of Nutrition</italic></source><year>2004</year><volume>134</volume><issue>4</issue><fpage>785</fpage><lpage>791</lpage><pub-id pub-id-type="other">2-s2.0-1842425919</pub-id><pub-id pub-id-type="pmid">15051826</pub-id></element-citation></ref><ref id="B25"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Var&#x000ec;</surname><given-names>R.</given-names></name><name><surname>D'Archivio</surname><given-names>M.</given-names></name><name><surname>Filesi</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Protocatechuic acid induces antioxidant/detoxifying enzyme expression through JNK-mediated Nrf2 activation in murine macrophages</article-title><source><italic>Journal of Nutritional Biochemistry</italic></source><year>2011</year><volume>22</volume><issue>5</issue><fpage>409</fpage><lpage>417</lpage><pub-id pub-id-type="doi">10.1016/j.jnutbio.2010.03.008</pub-id><pub-id pub-id-type="other">2-s2.0-79954574731</pub-id><pub-id pub-id-type="pmid">20621462</pub-id></element-citation></ref><ref id="B26"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tarozzi</surname><given-names>A.</given-names></name><name><surname>Morroni</surname><given-names>F.</given-names></name><name><surname>Hrelia</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Neuroprotective effects of anthocyanins and their in vivo metabolites in SH-SY5Y cells</article-title><source><italic>Neuroscience Letters</italic></source><year>2007</year><volume>424</volume><issue>1</issue><fpage>36</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1016/j.neulet.2007.07.017</pub-id><pub-id pub-id-type="other">2-s2.0-34548010792</pub-id><pub-id pub-id-type="pmid">17709193</pub-id></element-citation></ref><ref id="B27"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>G.-F.</given-names></name><name><surname>An</surname><given-names>L.-J.</given-names></name><name><surname>Jiang</surname><given-names>B.</given-names></name><name><surname>Guan</surname><given-names>S.</given-names></name><name><surname>Bao</surname><given-names>Y.-M.</given-names></name></person-group><article-title>
<italic>Alpinia</italic> protocatechuic acid protects against oxidative damage in vitro and reduces oxidative stress in vivo</article-title><source><italic>Neuroscience Letters</italic></source><year>2006</year><volume>403</volume><issue>3</issue><fpage>206</fpage><lpage>210</lpage><pub-id pub-id-type="doi">10.1016/j.neulet.2006.02.057</pub-id><pub-id pub-id-type="other">2-s2.0-33745737781</pub-id><pub-id pub-id-type="pmid">16806694</pub-id></element-citation></ref><ref id="B28"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chou</surname><given-names>T.-H.</given-names></name><name><surname>Ding</surname><given-names>H.-Y.</given-names></name><name><surname>Lin</surname><given-names>R.-J.</given-names></name><name><surname>Liang</surname><given-names>J.-Y.</given-names></name><name><surname>Liang</surname><given-names>C.-H.</given-names></name></person-group><article-title>Inhibition of melanogenesis and oxidation by protocatechuic acid from <italic>Origanum vulgare</italic> (Oregano)</article-title><source><italic>Journal of Natural Products</italic></source><year>2010</year><volume>73</volume><issue>11</issue><fpage>1767</fpage><lpage>1774</lpage><pub-id pub-id-type="doi">10.1021/np100281g</pub-id><pub-id pub-id-type="other">2-s2.0-78650206441</pub-id><pub-id pub-id-type="pmid">20973550</pub-id></element-citation></ref><ref id="B29"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Shi</surname><given-names>G.-F.</given-names></name><name><surname>Liu</surname><given-names>X.-Z.</given-names></name><name><surname>An</surname><given-names>L.-J.</given-names></name><name><surname>Guan</surname><given-names>S.</given-names></name></person-group><article-title>Anti-ageing effects of protocatechuic acid from <italic>Alpinia</italic> on spleen and liver antioxidative system of senescent mice</article-title><source><italic>Cell Biochemistry and Function</italic></source><year>2011</year><volume>29</volume><issue>4</issue><fpage>342</fpage><lpage>347</lpage><pub-id pub-id-type="doi">10.1002/cbf.1757</pub-id><pub-id pub-id-type="other">2-s2.0-79958814659</pub-id><pub-id pub-id-type="pmid">21491470</pub-id></element-citation></ref><ref id="B30"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>S.-J.</given-names></name><name><surname>Yin</surname><given-names>M.-C.</given-names></name></person-group><article-title>Anti-glycative and anti-inflammatory effects of protocatechuic acid in brain of mice treated by d-galactose</article-title><source><italic>Food and Chemical Toxicology</italic></source><year>2012</year><volume>50</volume><issue>9</issue><fpage>3198</fpage><lpage>3205</lpage><pub-id pub-id-type="doi">10.1016/j.fct.2012.05.056</pub-id><pub-id pub-id-type="other">2-s2.0-84864130933</pub-id><pub-id pub-id-type="pmid">22687555</pub-id></element-citation></ref><ref id="B31"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Semaming</surname><given-names>Y.</given-names></name><name><surname>Kumfu</surname><given-names>S.</given-names></name><name><surname>Pannangpetch</surname><given-names>P.</given-names></name><name><surname>Chattipakorn</surname><given-names>S. C.</given-names></name><name><surname>Chattipakorn</surname><given-names>N.</given-names></name></person-group><article-title>Protocatechuic acid exerts a cardioprotective effect in type 1 diabetic rats</article-title><source><italic>Journal of Endocrinology</italic></source><year>2014</year><volume>223</volume><issue>1</issue><fpage>13</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1530/joe-14-0273</pub-id><pub-id pub-id-type="pmid">25074852</pub-id></element-citation></ref><ref id="B32"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feghali</surname><given-names>C. A.</given-names></name><name><surname>Wright</surname><given-names>T. M.</given-names></name></person-group><article-title>Cytokines in acute and chronic inflammation</article-title><source><italic>Frontiers in Bioscience</italic></source><year>1997</year><volume>2</volume><fpage>d12</fpage><lpage>d26</lpage><pub-id pub-id-type="other">2-s2.0-0001929693</pub-id><pub-id pub-id-type="pmid">9159205</pub-id></element-citation></ref><ref id="B33"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lawrence</surname><given-names>T.</given-names></name><name><surname>Gilroy</surname><given-names>D. W.</given-names></name></person-group><article-title>Chronic inflammation: a failure of resolution?</article-title><source><italic>International Journal of Experimental Pathology</italic></source><year>2007</year><volume>88</volume><issue>2</issue><fpage>85</fpage><lpage>94</lpage><pub-id pub-id-type="other">2-s2.0-34147190086</pub-id><pub-id pub-id-type="doi">10.1111/j.1365-2613.2006.00507.x</pub-id><pub-id pub-id-type="pmid">17408451</pub-id></element-citation></ref><ref id="B34"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fonseca</surname><given-names>M. I.</given-names></name><name><surname>Chu</surname><given-names>S.-H.</given-names></name><name><surname>Berci</surname><given-names>A. M.</given-names></name><etal/></person-group><article-title>Contribution of complement activation pathways to neuropathology differs among mouse models of Alzheimer's disease</article-title><source><italic>Journal of Neuroinflammation</italic></source><year>2011</year><volume>8</volume><issue>1, article 4</issue><pub-id pub-id-type="doi">10.1186/1742-2094-8-4</pub-id><pub-id pub-id-type="other">2-s2.0-78651377751</pub-id></element-citation></ref><ref id="B35"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Medzhitov</surname><given-names>R.</given-names></name></person-group><article-title>Inflammation 2010: new adventures of an old flame</article-title><source><italic>Cell</italic></source><year>2010</year><volume>140</volume><issue>6</issue><fpage>771</fpage><lpage>776</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2010.03.006</pub-id><pub-id pub-id-type="other">2-s2.0-77950345093</pub-id><pub-id pub-id-type="pmid">20303867</pub-id></element-citation></ref><ref id="B36"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manicone</surname><given-names>A. M.</given-names></name><name><surname>McGuire</surname><given-names>J. K.</given-names></name></person-group><article-title>Matrix metalloproteinases as modulators of inflammation</article-title><source><italic>Seminars in Cell and Developmental Biology</italic></source><year>2008</year><volume>19</volume><issue>1</issue><fpage>34</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1016/j.semcdb.2007.07.003</pub-id><pub-id pub-id-type="other">2-s2.0-36849094431</pub-id><pub-id pub-id-type="pmid">17707664</pub-id></element-citation></ref><ref id="B37"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lawrence</surname><given-names>T.</given-names></name><name><surname>Fong</surname><given-names>C.</given-names></name></person-group><article-title>The resolution of inflammation: anti-inflammatory roles for NF-<italic>&#x003ba;</italic>B</article-title><source><italic>The International Journal of Biochemistry &#x00026; Cell Biology</italic></source><year>2010</year><volume>42</volume><issue>4</issue><fpage>519</fpage><lpage>523</lpage><pub-id pub-id-type="doi">10.1016/j.biocel.2009.12.016</pub-id><pub-id pub-id-type="other">2-s2.0-77649183653</pub-id><pub-id pub-id-type="pmid">20026420</pub-id></element-citation></ref><ref id="B38"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Min</surname><given-names>S.-W.</given-names></name><name><surname>Ryu</surname><given-names>S.-N.</given-names></name><name><surname>Kim</surname><given-names>D.-H.</given-names></name></person-group><article-title>Anti-inflammatory effects of black rice, cyanidin-3-O-<italic>&#x003b2;</italic>-d-glycoside, and its metabolites, cyanidin and protocatechuic acid</article-title><source><italic>International Immunopharmacology</italic></source><year>2010</year><volume>10</volume><issue>8</issue><fpage>959</fpage><lpage>966</lpage><pub-id pub-id-type="doi">10.1016/j.intimp.2010.05.009</pub-id><pub-id pub-id-type="other">2-s2.0-77954955441</pub-id><pub-id pub-id-type="pmid">20669401</pub-id></element-citation></ref><ref id="B39"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>D.</given-names></name><name><surname>Wei</surname><given-names>X.</given-names></name><name><surname>Yan</surname><given-names>X.</given-names></name><name><surname>Jin</surname><given-names>T.</given-names></name><name><surname>Ling</surname><given-names>W.</given-names></name></person-group><article-title>Protocatechuic acid, a metabolite of anthocyanins, inhibits monocyte adhesion and reduces atherosclerosis in apolipoprotein E-deficient mice</article-title><source><italic>Journal of Agricultural and Food Chemistry</italic></source><year>2010</year><volume>58</volume><issue>24</issue><fpage>12722</fpage><lpage>12728</lpage><pub-id pub-id-type="doi">10.1021/jf103427j</pub-id><pub-id pub-id-type="other">2-s2.0-78650338831</pub-id><pub-id pub-id-type="pmid">21090717</pub-id></element-citation></ref><ref id="B40"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>D.</given-names></name><name><surname>Zou</surname><given-names>T.</given-names></name><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Yan</surname><given-names>X.</given-names></name><name><surname>Ling</surname><given-names>W.</given-names></name></person-group><article-title>Cyanidin-3-O-<italic>&#x003b2;</italic>-glucoside with the aid of its metabolite protocatechuic acid, reduces monocyte infiltration in apolipoprotein E-deficient mice</article-title><source><italic>Biochemical Pharmacology</italic></source><year>2011</year><volume>82</volume><issue>7</issue><fpage>713</fpage><lpage>719</lpage><pub-id pub-id-type="doi">10.1016/j.bcp.2011.04.007</pub-id><pub-id pub-id-type="other">2-s2.0-80051791999</pub-id><pub-id pub-id-type="pmid">21569764</pub-id></element-citation></ref><ref id="B41"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>J.-J.</given-names></name><name><surname>Jung</surname><given-names>J.-S.</given-names></name><name><surname>Hong</surname><given-names>Y.-J.</given-names></name><etal/></person-group><article-title>Protective effect of protocatechuic acid isopropyl ester against murine models of sepsis: inhibition of TNF-alpha and nitric oxide production and augmentation of IL-10</article-title><source><italic>Biological and Pharmaceutical Bulletin</italic></source><year>2004</year><volume>27</volume><issue>12</issue><fpage>2024</fpage><lpage>2027</lpage><pub-id pub-id-type="doi">10.1248/bpb.27.2024</pub-id><pub-id pub-id-type="other">2-s2.0-21644447411</pub-id><pub-id pub-id-type="pmid">15577225</pub-id></element-citation></ref><ref id="B42"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosen</surname><given-names>E. D.</given-names></name><name><surname>Spiegelman</surname><given-names>B. M.</given-names></name></person-group><article-title>Adipocytes as regulators of energy balance and glucose homeostasis</article-title><source><italic>Nature</italic></source><year>2006</year><volume>444</volume><issue>7121</issue><fpage>847</fpage><lpage>853</lpage><pub-id pub-id-type="doi">10.1038/nature05483</pub-id><pub-id pub-id-type="other">2-s2.0-33845864967</pub-id><pub-id pub-id-type="pmid">17167472</pub-id></element-citation></ref><ref id="B43"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Selvin</surname><given-names>E.</given-names></name><name><surname>Steffes</surname><given-names>M. W.</given-names></name><name><surname>Zhu</surname><given-names>H.</given-names></name><etal/></person-group><article-title>Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults</article-title><source><italic>The New England Journal of Medicine</italic></source><year>2010</year><volume>362</volume><issue>9</issue><fpage>800</fpage><lpage>811</lpage><pub-id pub-id-type="doi">10.1056/nejmoa0908359</pub-id><pub-id pub-id-type="other">2-s2.0-77649329576</pub-id><pub-id pub-id-type="pmid">20200384</pub-id></element-citation></ref><ref id="B44"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nathan</surname><given-names>D. M.</given-names></name><name><surname>Cleary</surname><given-names>P. A.</given-names></name><name><surname>Backlund</surname><given-names>J.-Y. C.</given-names></name><etal/></person-group><article-title>Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes</article-title><source><italic>The New England Journal of Medicine</italic></source><year>2005</year><volume>353</volume><issue>25</issue><fpage>2643</fpage><lpage>2653</lpage><pub-id pub-id-type="doi">10.1056/nejmoa052187</pub-id><pub-id pub-id-type="other">2-s2.0-29144453326</pub-id><pub-id pub-id-type="pmid">16371630</pub-id></element-citation></ref><ref id="B45"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>J. R.</given-names></name><name><surname>Barrick</surname><given-names>C.</given-names></name><name><surname>Kim</surname><given-names>K.-A.</given-names></name><etal/></person-group><article-title>Deletion of PPAR<italic>&#x003b3;</italic> in adipose tissues of mice protects against high fat diet-induced obesity and insulin resistance</article-title><source><italic>Proceedings of the National Academy of Sciences of the United States of America</italic></source><year>2005</year><volume>102</volume><issue>17</issue><fpage>6207</fpage><lpage>6212</lpage><pub-id pub-id-type="doi">10.1073/pnas.0306743102</pub-id><pub-id pub-id-type="other">2-s2.0-20944439189</pub-id><pub-id pub-id-type="pmid">15833818</pub-id></element-citation></ref><ref id="B46"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scazzocchio</surname><given-names>B.</given-names></name><name><surname>Var&#x000ec;</surname><given-names>R.</given-names></name><name><surname>Filesi</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Cyanidin-3-O-<italic>&#x003b2;</italic>-glucoside and protocatechuic acid exert insulin-like effects by upregulating PPAR<italic>&#x003b3;</italic> activity in human omental adipocytes</article-title><source><italic>Diabetes</italic></source><year>2011</year><volume>60</volume><issue>9</issue><fpage>2234</fpage><lpage>2244</lpage><pub-id pub-id-type="doi">10.2337/db10-1461</pub-id><pub-id pub-id-type="other">2-s2.0-80052903790</pub-id><pub-id pub-id-type="pmid">21788573</pub-id></element-citation></ref><ref id="B47"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harini</surname><given-names>R.</given-names></name><name><surname>Pugalendi</surname><given-names>K. V.</given-names></name></person-group><article-title>Antihyperglycemic effect of protocatechuic acid on streptozotocin-diabetic rats</article-title><source><italic>Journal of Basic and Clinical Physiology and Pharmacology</italic></source><year>2010</year><volume>21</volume><issue>1</issue><fpage>79</fpage><lpage>91</lpage><pub-id pub-id-type="other">2-s2.0-77953175292</pub-id><pub-id pub-id-type="pmid">20506690</pub-id></element-citation></ref><ref id="B48"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D'Archivio</surname><given-names>M.</given-names></name><name><surname>Santangelo</surname><given-names>C.</given-names></name><name><surname>Scazzocchio</surname><given-names>B.</given-names></name><etal/></person-group><article-title>Modulatory effects of polyphenols on apoptosis induction: relevance for cancer prevention</article-title><source><italic>International Journal of Molecular Sciences</italic></source><year>2008</year><volume>9</volume><issue>3</issue><fpage>213</fpage><lpage>228</lpage><pub-id pub-id-type="other">2-s2.0-41649105058</pub-id><pub-id pub-id-type="doi">10.3390/ijms9030213</pub-id><pub-id pub-id-type="pmid">19325744</pub-id></element-citation></ref><ref id="B49"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giovannini</surname><given-names>C.</given-names></name><name><surname>Scazzocchio</surname><given-names>B.</given-names></name><name><surname>Var&#x000ec;</surname><given-names>R.</given-names></name><name><surname>Santangelo</surname><given-names>C.</given-names></name><name><surname>D'Archivio</surname><given-names>M.</given-names></name><name><surname>Masella</surname><given-names>R.</given-names></name></person-group><article-title>Apoptosis in cancer and atherosclerosis: polyphenol activities</article-title><source><italic>Annali dell'Istituto Superiore di Sanita</italic></source><year>2007</year><volume>43</volume><issue>4</issue><fpage>406</fpage><lpage>416</lpage><pub-id pub-id-type="other">2-s2.0-38949183939</pub-id></element-citation></ref><ref id="B50"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou-Stache</surname><given-names>J.</given-names></name><name><surname>Buettner</surname><given-names>R.</given-names></name><name><surname>Artmann</surname><given-names>G.</given-names></name><name><surname>Mittermayer</surname><given-names>C.</given-names></name><name><surname>Bosserhoff</surname><given-names>A. K.</given-names></name></person-group><article-title>Inhibition of TNF-<italic>&#x003b1;</italic> induced cell death in human umbilical vein endothelial cells and Jurkat cells by protocatechuic acid</article-title><source><italic>Medical and Biological Engineering and Computing</italic></source><year>2002</year><volume>40</volume><issue>6</issue><fpage>698</fpage><lpage>703</lpage><pub-id pub-id-type="doi">10.1007/bf02345308</pub-id><pub-id pub-id-type="other">2-s2.0-0036865674</pub-id><pub-id pub-id-type="pmid">12507320</pub-id></element-citation></ref><ref id="B51"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guan</surname><given-names>S.</given-names></name><name><surname>Jiang</surname><given-names>B.</given-names></name><name><surname>Bao</surname><given-names>Y. M.</given-names></name><name><surname>An</surname><given-names>L. J.</given-names></name></person-group><article-title>Protocatechuic acid suppresses MPP<sup>+</sup>-induced mitochondrial dysfunction and apoptotic cell death in PC12 cells</article-title><source><italic>Food and Chemical Toxicology</italic></source><year>2006</year><volume>44</volume><issue>10</issue><fpage>1659</fpage><lpage>1666</lpage><pub-id pub-id-type="other">2-s2.0-33747043799</pub-id><pub-id pub-id-type="doi">10.1016/j.fct.2006.05.004</pub-id><pub-id pub-id-type="pmid">16806628</pub-id></element-citation></ref><ref id="B52"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guan</surname><given-names>S.</given-names></name><name><surname>Ge</surname><given-names>D.</given-names></name><name><surname>Liu</surname><given-names>T.-Q.</given-names></name><name><surname>Ma</surname><given-names>X.-H.</given-names></name><name><surname>Cui</surname><given-names>Z.-F.</given-names></name></person-group><article-title>Protocatechuic acid promotes cell proliferation and reduces basal apoptosis in cultured neural stem cells</article-title><source><italic>Toxicology in Vitro</italic></source><year>2009</year><volume>23</volume><issue>2</issue><fpage>201</fpage><lpage>208</lpage><pub-id pub-id-type="doi">10.1016/j.tiv.2008.11.008</pub-id><pub-id pub-id-type="other">2-s2.0-59249091238</pub-id><pub-id pub-id-type="pmid">19095056</pub-id></element-citation></ref><ref id="B53"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guan</surname><given-names>S.</given-names></name><name><surname>Bao</surname><given-names>Y.-M.</given-names></name><name><surname>Jiang</surname><given-names>B.</given-names></name><name><surname>An</surname><given-names>L.-J.</given-names></name></person-group><article-title>Protective effect of protocatechuic acid from <italic>Alpinia oxyphylla</italic> on hydrogen peroxide-induced oxidative PC12 cell death</article-title><source><italic>European Journal of Pharmacology</italic></source><year>2006</year><volume>538</volume><issue>1&#x02013;3</issue><fpage>73</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1016/j.ejphar.2006.03.065</pub-id><pub-id pub-id-type="other">2-s2.0-33646511724</pub-id><pub-id pub-id-type="pmid">16678817</pub-id></element-citation></ref><ref id="B54"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>H.-N.</given-names></name><name><surname>An</surname><given-names>C.-N.</given-names></name><name><surname>Xu</surname><given-names>M.</given-names></name><name><surname>Guo</surname><given-names>D.-A.</given-names></name><name><surname>Li</surname><given-names>M.</given-names></name><name><surname>Pu</surname><given-names>X.-P.</given-names></name></person-group><article-title>Protocatechuic acid inhibits rat pheochromocytoma cell damage induced by a dopaminergic neurotoxin</article-title><source><italic>Biological and Pharmaceutical Bulletin</italic></source><year>2009</year><volume>32</volume><issue>11</issue><fpage>1866</fpage><lpage>1869</lpage><pub-id pub-id-type="doi">10.1248/bpb.32.1866</pub-id><pub-id pub-id-type="other">2-s2.0-70350731121</pub-id><pub-id pub-id-type="pmid">19881299</pub-id></element-citation></ref><ref id="B55"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tseng</surname><given-names>T.-H.</given-names></name><name><surname>Wang</surname><given-names>C.-J.</given-names></name><name><surname>Kao</surname><given-names>E.-S.</given-names></name><name><surname>Chu</surname><given-names>H.-Y.</given-names></name></person-group><article-title>Hibiscus protocatechuic acid protects against oxidative damage induced by tert-butylhydroperoxide in rat primary hepatocytes</article-title><source><italic>Chemico-Biological Interactions</italic></source><year>1996</year><volume>101</volume><issue>2</issue><fpage>137</fpage><lpage>148</lpage><pub-id pub-id-type="other">2-s2.0-0030583290</pub-id><pub-id pub-id-type="doi">10.1016/0009-2797(96)03721-0</pub-id><pub-id pub-id-type="pmid">8760395</pub-id></element-citation></ref><ref id="B56"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tseng</surname><given-names>T.-H.</given-names></name><name><surname>Kao</surname><given-names>T.-W.</given-names></name><name><surname>Chu</surname><given-names>C.-Y.</given-names></name><name><surname>Chou</surname><given-names>F.-P.</given-names></name><name><surname>Lin</surname><given-names>W.-L.</given-names></name><name><surname>Wang</surname><given-names>C.-J.</given-names></name></person-group><article-title>Induction of apoptosis by <italic>Hibiscus protocatechuic</italic> acid in human leukemia cells via reduction of retinoblastoma (RB) phosphorylation and Bcl-2 expression</article-title><source><italic>Biochemical Pharmacology</italic></source><year>2000</year><volume>60</volume><issue>3</issue><fpage>307</fpage><lpage>315</lpage><pub-id pub-id-type="doi">10.1016/s0006-2952(00)00322-1</pub-id><pub-id pub-id-type="other">2-s2.0-0034256987</pub-id><pub-id pub-id-type="pmid">10856425</pub-id></element-citation></ref><ref id="B57"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>H.-H.</given-names></name><name><surname>Chen</surname><given-names>J.-H.</given-names></name><name><surname>Huang</surname><given-names>C.-C.</given-names></name><name><surname>Wang</surname><given-names>C.-J.</given-names></name></person-group><article-title>Apoptotic effect of 3,4-dihydroxybenzoic acid on human gastric carcinoma cells involving JNK/p38 MAPK signaling activation</article-title><source><italic>International Journal of Cancer</italic></source><year>2007</year><volume>120</volume><issue>11</issue><fpage>2306</fpage><lpage>2316</lpage><pub-id pub-id-type="doi">10.1002/ijc.22571</pub-id><pub-id pub-id-type="other">2-s2.0-34247381960</pub-id></element-citation></ref><ref id="B58"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yip</surname><given-names>E. C. H.</given-names></name><name><surname>Chan</surname><given-names>A. S. L.</given-names></name><name><surname>Pang</surname><given-names>H.</given-names></name><name><surname>Tam</surname><given-names>Y. K.</given-names></name><name><surname>Wong</surname><given-names>Y. H.</given-names></name></person-group><article-title>Protocatechuic acid induces cell death in HepG2 hepatocellular carcinoma cells through a c-Jun N-terminal kinase-dependent mechanism</article-title><source><italic>Cell Biology and Toxicology</italic></source><year>2006</year><volume>22</volume><issue>4</issue><fpage>293</fpage><lpage>302</lpage><pub-id pub-id-type="other">2-s2.0-33745913944</pub-id><pub-id pub-id-type="doi">10.1007/s10565-006-0082-4</pub-id><pub-id pub-id-type="pmid">16835731</pub-id></element-citation></ref><ref id="B59"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yin</surname><given-names>M.-C.</given-names></name><name><surname>Lin</surname><given-names>C.-C.</given-names></name><name><surname>Wu</surname><given-names>H.-C.</given-names></name><name><surname>Tsao</surname><given-names>S.-M.</given-names></name><name><surname>Hsu</surname><given-names>C.-K.</given-names></name></person-group><article-title>Apoptotic effects of protocatechuic acid in human breast, lung, liver, cervix, and prostate cancer cells: potential mechanisms of action</article-title><source><italic>Journal of Agricultural and Food Chemistry</italic></source><year>2009</year><volume>57</volume><issue>14</issue><fpage>6468</fpage><lpage>6473</lpage><pub-id pub-id-type="doi">10.1021/jf9004466</pub-id><pub-id pub-id-type="other">2-s2.0-67650905172</pub-id><pub-id pub-id-type="pmid">19601677</pub-id></element-citation></ref><ref id="B60"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peiffer</surname><given-names>D. S.</given-names></name><name><surname>Zimmerman</surname><given-names>N. P.</given-names></name><name><surname>Wang</surname><given-names>L.-S.</given-names></name><etal/></person-group><article-title>Chemoprevention of esophageal cancer with black raspberries, their component anthocyanins, and a major anthocyanin metabolite, protocatechuic acid</article-title><source><italic>Cancer Prevention Research</italic></source><year>2014</year><volume>7</volume><issue>6</issue><fpage>574</fpage><lpage>584</lpage><pub-id pub-id-type="doi">10.1158/1940-6207.capr-14-0003</pub-id><pub-id pub-id-type="pmid">24667581</pub-id></element-citation></ref><ref id="B61"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuete</surname><given-names>V.</given-names></name><name><surname>Nana</surname><given-names>F.</given-names></name><name><surname>Ngameni</surname><given-names>B.</given-names></name><name><surname>Mbaveng</surname><given-names>A. T.</given-names></name><name><surname>Keumedjio</surname><given-names>F.</given-names></name><name><surname>Ngadjui</surname><given-names>B. T.</given-names></name></person-group><article-title>Antimicrobial activity of the crude extract, fractions and compounds from stem bark of <italic>Ficus ovata</italic> (Moraceae)</article-title><source><italic>Journal of Ethnopharmacology</italic></source><year>2009</year><volume>124</volume><issue>3</issue><fpage>556</fpage><lpage>561</lpage><pub-id pub-id-type="other">2-s2.0-67650688129</pub-id><pub-id pub-id-type="doi">10.1016/j.jep.2009.05.003</pub-id><pub-id pub-id-type="pmid">19450673</pub-id></element-citation></ref><ref id="B62"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>W. H.</given-names></name><name><surname>Hsu</surname><given-names>C. C.</given-names></name><name><surname>Yin</surname><given-names>M. C.</given-names></name></person-group><article-title>In vitro anti-Helicobacter pylori activity of diallyl sulphides and protocatechuic acid</article-title><source><italic>Phytotherapy Research</italic></source><year>2008</year><volume>22</volume><issue>1</issue><fpage>53</fpage><lpage>57</lpage><pub-id pub-id-type="pmid">17705145</pub-id></element-citation></ref><ref id="B63"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yin</surname><given-names>M.-C.</given-names></name><name><surname>Chao</surname><given-names>C.-Y.</given-names></name></person-group><article-title>Anti-Campylobacter, anti-aerobic, and anti-oxidative effects of roselle calyx extract and protocatechuic acid in ground beef</article-title><source><italic>International Journal of Food Microbiology</italic></source><year>2008</year><volume>127</volume><issue>1-2</issue><fpage>73</fpage><lpage>77</lpage><pub-id pub-id-type="other">2-s2.0-50649083922</pub-id><pub-id pub-id-type="doi">10.1016/j.ijfoodmicro.2008.06.002</pub-id><pub-id pub-id-type="pmid">18620770</pub-id></element-citation></ref><ref id="B64"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jayaraman</surname><given-names>P.</given-names></name><name><surname>Sakharkar</surname><given-names>M. K.</given-names></name><name><surname>Lim</surname><given-names>C. S.</given-names></name><name><surname>Tang</surname><given-names>T. H.</given-names></name><name><surname>Sakharkar</surname><given-names>K. R.</given-names></name></person-group><article-title>Activity and interactions of antibiotic and phytochemical combinations against pseudomonas aeruginosa in vitro</article-title><source><italic>International Journal of Biological Sciences</italic></source><year>2010</year><volume>6</volume><issue>6</issue><fpage>556</fpage><lpage>568</lpage><pub-id pub-id-type="other">2-s2.0-78650054412</pub-id><pub-id pub-id-type="pmid">20941374</pub-id></element-citation></ref><ref id="B65"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chao</surname><given-names>C.-Y.</given-names></name><name><surname>Yin</surname><given-names>M.-C.</given-names></name></person-group><article-title>Antibacterial effects of roselle calyx extracts and protocatechuic acid in ground beef and apple juice</article-title><source><italic>Foodborne Pathogens and Disease</italic></source><year>2009</year><volume>6</volume><issue>2</issue><fpage>201</fpage><lpage>206</lpage><pub-id pub-id-type="doi">10.1089/fpd.2008.0187</pub-id><pub-id pub-id-type="other">2-s2.0-61349195728</pub-id><pub-id pub-id-type="pmid">19099360</pub-id></element-citation></ref></ref-list></back><floats-group><table-wrap id="tab1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Summary of <italic>in vitro</italic> studies of antioxidant activities of PCA.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Model</th><th align="left" rowspan="1" colspan="1">Method</th><th align="center" rowspan="1" colspan="1">PCA concentration</th><th align="left" rowspan="1" colspan="1">Major finding</th><th align="left" rowspan="1" colspan="1">Interpretation</th><th align="center" rowspan="1" colspan="1">Reference</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Biochemical assay</td><td align="left" rowspan="1" colspan="1">(i) TBAR assay<break/>(ii) H<sub>2</sub>O<sub>2</sub> assay<break/>(iii) DPPH<sup>.</sup> assay</td><td align="center" rowspan="1" colspan="1">0.05 and 0.10&#x02009;mg/mL</td><td align="left" rowspan="1" colspan="1">(i) PCA increased % inhibition of lipid peroxidation<break/>(ii) PCA increased % scavenging of H<sub>2</sub>O<sub>2</sub>&#x02009;<break/>(iii) PCA increased % scavenging of DPPH<sup>.</sup></td><td align="left" rowspan="1" colspan="1">PCA exerted antioxidant activity </td><td align="center" rowspan="1" colspan="1">[<xref rid="B23" ref-type="bibr">22</xref>]</td></tr><tr><td align="center" colspan="6" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="1" colspan="1">J774 A.1 macrophages</td><td align="left" rowspan="1" colspan="1">J774 A.1 macrophages </td><td align="center" rowspan="1" colspan="1">3 and 25&#x02009;mol/L</td><td align="left" rowspan="1" colspan="1">(i) PCA decreased oxidation of LDL<break/>(ii) PCA inhibited O<sub>2</sub> and H<sub>2</sub>O<sub>2</sub> production<break/>(iii) PCA increased GSH content<break/>(iv) PCA restored GR and GPx activities<break/>(v) PCA restored the <italic>&#x003b3;</italic>-GCS mRNA, GR, and GPx expression </td><td align="left" rowspan="1" colspan="1">PCA had an antioxidant activity via activation of mRNA transcription of GSH-related enzymes</td><td align="center" rowspan="1" colspan="1">[<xref rid="B24" ref-type="bibr">23</xref>]</td></tr><tr><td align="center" colspan="6" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="1" colspan="1">J774 A.1 macrophages</td><td align="left" rowspan="1" colspan="1">Direct PCA application to cells</td><td align="center" rowspan="1" colspan="1">25&#x02009;<italic>&#x003bc;</italic>M</td><td align="left" rowspan="1" colspan="1">(i) PCA increased GSH, GPx, and GR expression<break/>(ii) PCA increased Nrf2 expression and activation<break/>(iii) PCA increased JNK mRNA level</td><td align="left" rowspan="1" colspan="1">PCA increased macrophage endogenous antioxidants via JNK-mediated Nrf2 activation </td><td align="center" rowspan="1" colspan="1">[<xref rid="B25" ref-type="bibr">24</xref>]</td></tr><tr><td align="center" colspan="6" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Human neuronal cell line</td><td align="left" rowspan="1" colspan="1">H<sub>2</sub>O<sub>2</sub>-induced oxidative stress</td><td align="center" rowspan="1" colspan="1">25, 50, and 100&#x02009;<italic>&#x003bc;</italic>M</td><td align="left" rowspan="1" colspan="1">(i) PCA inhibited ROS formation at cytosolic level<break/>(ii) PCA inhibited apoptotic events<break/>(iii) PCA improved mitochondrial function<break/>(iv) PCA decreased DNA fragmentation</td><td align="left" rowspan="1" colspan="1">PCA reduced apoptosis via ROS reduction, improved mitochondrial function, and inhibited DNA fragmentation</td><td align="center" rowspan="1" colspan="1">[<xref rid="B26" ref-type="bibr">25</xref>]</td></tr><tr><td align="center" colspan="6" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="1" colspan="1">PC12 cells</td><td align="left" rowspan="1" colspan="1">H<sub>2</sub>O<sub>2</sub>-induced oxidative damage </td><td align="center" rowspan="1" colspan="1">50, 100, 150, and 200&#x02009;<italic>&#x003bc;</italic>M</td><td align="left" rowspan="1" colspan="1">(i) PCA increased cell viability<break/>(ii) PCA decreased % LDH release </td><td align="left" rowspan="1" colspan="1">PCA prevented H<sub>2</sub>O<sub>2</sub>-induced cell death</td><td align="center" rowspan="1" colspan="1">[<xref rid="B27" ref-type="bibr">26</xref>]</td></tr><tr><td align="center" colspan="6" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="1" colspan="1">BNLCL2 cells</td><td align="left" rowspan="1" colspan="1">H<sub>2</sub>O<sub>2</sub>-induced oxidative damage</td><td align="center" rowspan="1" colspan="1">1, 5, 10, 20, and 100&#x02009;<italic>&#x003bc;</italic>g/mL</td><td align="left" rowspan="1" colspan="1">(i) PCA affected DPPH scavenging activity <break/>(ii) PCA inhibited liposome peroxidation <break/>(iii) PCA reduced intracellular ROS level</td><td align="left" rowspan="1" colspan="1">PCA had a radical scavenging activity and antioxidant property</td><td align="center" rowspan="1" colspan="1">[<xref rid="B28" ref-type="bibr">27</xref>]</td></tr></tbody></table></table-wrap><table-wrap id="tab2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Summary of <italic>in vivo</italic> studies of antioxidant activities of PCA.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Model</th><th align="left" rowspan="1" colspan="1">Method</th><th align="center" rowspan="1" colspan="1">PCA dose/route/duration</th><th align="left" rowspan="1" colspan="1">Major finding</th><th align="left" rowspan="1" colspan="1">Interpretation</th><th align="center" rowspan="1" colspan="1">Reference</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Sprague-Dawley rat</td><td align="left" rowspan="1" colspan="1">STZ-induced T1DM (50&#x02009;mg/kg, ip)</td><td align="center" rowspan="1" colspan="1">50, 100&#x02009;mg/kg, po</td><td align="left" rowspan="1" colspan="1">(i) PCA decreased plasma MDA<break/>(ii) PCA decreased cardiac MDA<break/>(iii) PCA decreased mitochondrial ROS production</td><td align="left" rowspan="1" colspan="1">PCA deceased oxidative stress in T1DM rats</td><td align="center" rowspan="1" colspan="1">[<xref rid="B31" ref-type="bibr">30</xref>]</td></tr><tr><td align="center" colspan="6" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Sprague-Dawley rat</td><td align="left" rowspan="1" colspan="1">H<sub>2</sub>O<sub>2</sub>-induced oxidative damage in young and age rats</td><td align="center" rowspan="1" colspan="1">5&#x02009;mg/kg/day for 7 days (ip)</td><td align="left" rowspan="1" colspan="1">(i) PCA improved scores during the passive avoidance testing<break/>(ii) PCA decreased MDA in brain of aged rat<break/>(iii) PCA increased GSH-PX activity</td><td align="left" rowspan="1" colspan="1">PCA promoted endogenous antioxidant enzymatic activities and inhibited ROS generation</td><td align="center" rowspan="1" colspan="1">[<xref rid="B27" ref-type="bibr">26</xref>]</td></tr><tr><td align="center" colspan="6" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Mice </td><td align="left" rowspan="1" colspan="1">D-galactose-induced ROS and AGEs</td><td align="center" rowspan="1" colspan="1">0.5%, 1%, or 2% in diet for 8 weeks</td><td align="left" rowspan="1" colspan="1">(i) PCA decreased ROS and protein carbonyl content<break/>(ii) PCA retained GSH content<break/>(iii) PCA decreased CML, pentosidine, sorbitol, fructose, and methylglycoxal level in brain</td><td align="left" rowspan="1" colspan="1">PCA had antiglycative and antioxidant activity by retaining GSH</td><td align="center" rowspan="1" colspan="1">&#x02009;[<xref rid="B30" ref-type="bibr">29</xref>]</td></tr><tr><td align="center" colspan="6" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Mice</td><td align="left" rowspan="1" colspan="1">Young and aged</td><td align="center" rowspan="1" colspan="1">5 and 10&#x02009;mg/kg (ip) for 7 days</td><td align="left" rowspan="1" colspan="1">In aged rats<break/>&#x02009;&#x02009;(i) PCA elevated splenic weight <break/>&#x02009;&#x02009;(ii) PCA increased the activities of GSH-PX <break/>&#x02009;&#x02009;(iii) PCA increased catalase (CAT) activity<break/>&#x02009;&#x02009;(iv) PCA decreased malondialdehyde (MDA) level</td><td align="left" rowspan="1" colspan="1">PCA was a potential antiageing agent by promoting endogenous antioxidant enzymatic activities</td><td align="center" rowspan="1" colspan="1">[<xref rid="B29" ref-type="bibr">28</xref>]</td></tr><tr><td align="center" colspan="6" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Mice</td><td align="left" rowspan="1" colspan="1">STZ-induced DM (50&#x02009;mg/kg/iv)</td><td align="center" rowspan="1" colspan="1">1%, 2%, and 4% in diet for 8 weeks</td><td align="left" rowspan="1" colspan="1">(i) PCA at all concentrations decreased cardiac and renal MDA level<break/>(ii) PCA at 2% and 4% increased cardiac and renal GSH level <break/>(iii) PCA at 2% and 4% decreased cardiac and renal GSSG formation<break/>(iv) PCA at 2% and 4% increased GPX and catalase activity in cardiac and renal tissues</td><td align="left" rowspan="1" colspan="1">PCA had an antioxidative effect through the restoration of endogenous antioxidants</td><td align="center" rowspan="1" colspan="1">[<xref rid="B3" ref-type="bibr">3</xref>]</td></tr></tbody></table></table-wrap><table-wrap id="tab3" orientation="portrait" position="float"><label>Table 3</label><caption><p>Summary of <italic>in vitro</italic> studies of anti-inflammatory activities of PCA.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Model</th><th align="left" rowspan="1" colspan="1">Method</th><th align="center" rowspan="1" colspan="1">PCA concentration</th><th align="left" rowspan="1" colspan="1">Major finding</th><th align="left" rowspan="1" colspan="1">Interpretation</th><th align="center" rowspan="1" colspan="1">Reference</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">RAW 264.7 cells </td><td align="left" rowspan="1" colspan="1">Lipopolysaccharide- (LPS-) induced cellular damage</td><td align="center" rowspan="1" colspan="1">1, 2, 5, and 25&#x02009;<italic>&#x003bc;</italic>M</td><td align="left" rowspan="1" colspan="1">(i) PCA decreased TNF-<italic>&#x003b1;</italic> and IL-1<italic>&#x003b2;</italic>&#x02009;<break/>(ii) PCA decreased NO and PGE<sub>2</sub>&#x02009;<break/>(iii) PCA inhibited iNOS and COX-2 expression<break/>(iv) PCA inhibited IkB-<italic>&#x003b1;</italic> degradation<break/>(v) PCA inhibited NF-kB phosphorylation<break/>(vi) PCA inhibited p38, ERK, and JNK</td><td align="left" rowspan="1" colspan="1">PCA had anti-inflammatory effects by regulating NF-kB and MAPK activation</td><td align="center" rowspan="1" colspan="1">[<xref rid="B38" ref-type="bibr">37</xref>]</td></tr><tr><td align="center" colspan="6" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Mouse aortic endothelial cell (MAEC)</td><td align="left" rowspan="1" colspan="1">TNF-<italic>&#x003b1;</italic>-induced cellular damage </td><td align="center" rowspan="1" colspan="1">0.05, 0.5, 5.0, 10, 20, and 40&#x02009;<italic>&#x003bc;</italic>mol/L</td><td align="left" rowspan="1" colspan="1">(i) PCA inhibited adhesion of HL-60 cells to MAECs<break/>(ii) PCA suppressed VCAM-1 and ICAM-1 mRNA expression <break/>(iii) PCA reduced NF-kB activation</td><td align="left" rowspan="1" colspan="1">PCA had an anti-inflammatory effect by inhibiting monocyte adhesion molecules</td><td align="center" rowspan="1" colspan="1">[<xref rid="B39" ref-type="bibr">38</xref>]</td></tr><tr><td align="center" colspan="6" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Cell culture</td><td align="left" rowspan="1" colspan="1">Isolated peripheral blood monocytes (PBMs) from ApoE-deficient mice</td><td align="center" rowspan="1" colspan="1">0.125, 0.25, and 0.5&#x02009;<italic>&#x003bc;</italic>mol/L</td><td align="left" rowspan="1" colspan="1">(i) PCA decreased CCR2 protein and mRNA expression<break/>(ii) PCA inhibited mouse PBMs migration</td><td align="left" rowspan="1" colspan="1">PCA exerted antiatherogenic properties by inhibiting monocyte infiltration</td><td align="center" rowspan="1" colspan="1">[<xref rid="B40" ref-type="bibr">39</xref>]</td></tr></tbody></table></table-wrap><table-wrap id="tab4" orientation="portrait" position="float"><label>Table 4</label><caption><p>Summary of <italic>in vivo</italic> studies of anti-inflammatory activities of PCA.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Model</th><th align="left" rowspan="1" colspan="1">Method</th><th align="center" rowspan="1" colspan="1">PCA dose/route/duration</th><th align="left" rowspan="1" colspan="1">Major finding</th><th align="left" rowspan="1" colspan="1">Interpretation</th><th align="center" rowspan="1" colspan="1">Reference</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Mice</td><td align="left" rowspan="1" colspan="1">Carrageenan-induced inflammation in BALB/c mice</td><td align="center" rowspan="1" colspan="1">5 and 25&#x02009;mg/kg, po (24&#x02009;h)</td><td align="left" rowspan="1" colspan="1">(i) PCA reduced exudate<break/>(ii) PCA decreased protein content <break/>(iii) PCA reduced leukocyte number<break/>(iv) PCA inhibited TNF-<italic>&#x003b1;</italic>, IL-1<italic>&#x003b2;</italic>, and PGE<sub>2</sub> level<break/>(v) PCA inhibited COX-2 and NF-kB expression</td><td align="left" rowspan="1" colspan="1">PCA exerted anti-inflammatory effects by inhibiting NF-kB activation.</td><td align="center" rowspan="1" colspan="1">[<xref rid="B38" ref-type="bibr">37</xref>]</td></tr><tr><td align="center" colspan="6" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Mice</td><td align="left" rowspan="1" colspan="1">ApoE-deficient mice</td><td align="center" rowspan="1" colspan="1">0.033% (w/w) of diet for 20 weeks</td><td align="left" rowspan="1" colspan="1">(i) PCA reduced sinus plague area<break/>(ii) PCA decreased cholesterol accumulation in aortas<break/>(iii) PCA reduced VCAM-1 and ICAM-1 expression in aortas<break/>(iv) PCA reduced NF-kB binding activity<break/>(v) PCA reduced plasma-soluble VCAM-1 and ICAM-1 levels</td><td align="left" rowspan="1" colspan="1">PCA exerted antiatherosclerosis effects by inhibiting adhesion molecules and reducing NF-kB activation</td><td align="center" rowspan="1" colspan="1">[<xref rid="B39" ref-type="bibr">38</xref>]</td></tr><tr><td align="center" colspan="6" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Mice</td><td align="left" rowspan="1" colspan="1">Thioglycollate-induced peritonitis in ApoE-deficient mice</td><td align="center" rowspan="1" colspan="1">25&#x02009;mg/kg (po) for 11 days</td><td align="left" rowspan="1" colspan="1">(i) PCA decreased CCR2 protein and mRNA expression in PBMs of ApoE-deficient mice<break/>(ii) PCA reduced macrophage infiltration into the abdominal cavity</td><td align="left" rowspan="1" colspan="1">PCA exerted antiatherogenic properties by inhibiting monocyte/macrophage infiltration</td><td align="center" rowspan="1" colspan="1">[<xref rid="B40" ref-type="bibr">39</xref>]</td></tr><tr><td align="center" colspan="6" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Mice</td><td align="left" rowspan="1" colspan="1">LPS-induced sepsis (20&#x02009;mg/kg, ip)</td><td align="center" rowspan="1" colspan="1">50&#x02009;mg/kg (ip) single dose</td><td align="left" rowspan="1" colspan="1">(i) PCA reduced lethality <break/>(ii) PCA suppressed TNF-<italic>&#x003b1;</italic> and IL-10 <break/>(iii) PCA decreased plasma ALT levels<break/>(iv) PCA decreased plasma nitrite/nitrate levels<break/>(v) PCA decreased hepatic MDA levels</td><td align="left" rowspan="1" colspan="1">PCA exerted sepsis prevention properties by inhibiting inflammatory cytokines and antioxidant activity </td><td align="center" rowspan="1" colspan="1">[<xref rid="B41" ref-type="bibr">40</xref>]</td></tr><tr><td align="center" colspan="6" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Mice</td><td align="left" rowspan="1" colspan="1">STZ-induced DM<break/>(50&#x02009;mg/kg/iv)</td><td align="center" rowspan="1" colspan="1">1%, 2%, and 4% in diet for 8 weeks</td><td align="left" rowspan="1" colspan="1">(i) PCA lowered plasma PAI-1 levels<break/>(ii) PCA increased plasma AP-III levels<break/>(iii) PCA increased plasma protein C levels<break/>(iv) PCA lowered plasma CRP levels<break/>(v) PCA decreased plasma von Willebrand factor <break/>(vi) PCA reduced IL-6, TNF-<italic>&#x003b1;</italic>, and MCP-1 levels in heart and kidney</td><td align="left" rowspan="1" colspan="1">PCA exerted anticoagulatory and anti-inflammatory effects by lowering inflammatory cytokines</td><td align="center" rowspan="1" colspan="1">[<xref rid="B3" ref-type="bibr">3</xref>]</td></tr></tbody></table></table-wrap><table-wrap id="tab5" orientation="portrait" position="float"><label>Table 5</label><caption><p>Summary of <italic>in vitro</italic> study of antihyperglycemic activities of PCA.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Model</th><th align="left" rowspan="1" colspan="1">Model/method</th><th align="center" rowspan="1" colspan="1">PCA concentration</th><th align="left" rowspan="1" colspan="1">Major finding</th><th align="left" rowspan="1" colspan="1">Interpretation</th><th align="center" rowspan="1" colspan="1">Reference</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Human omental adipocytes and murine adipocyte 3T3-L1 cells</td><td align="left" rowspan="1" colspan="1">oxLDL-induced insulin resistance </td><td align="center" rowspan="1" colspan="1">100&#x02009;<italic>&#x003bc;</italic>M</td><td align="left" rowspan="1" colspan="1">(i) PCA increased glucose uptake<break/>(ii) PCA increased GLUT4 translocation<break/>(iii) PCA increased PPAR<italic>&#x003b3;</italic> activity<break/>(iv) PCA increased adiponectin </td><td align="left" rowspan="1" colspan="1">PCA exerted an insulin-like activity in adipocytes by increasing PPAR<italic>&#x003b3;</italic> activation</td><td align="center" rowspan="1" colspan="1">[<xref rid="B46" ref-type="bibr">45</xref>]</td></tr></tbody></table></table-wrap><table-wrap id="tab6" orientation="portrait" position="float"><label>Table 6</label><caption><p>Summary of <italic>in vivo</italic> studies of antihyperglycemic activities of PCA.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Model</th><th align="left" rowspan="1" colspan="1">Model/method</th><th align="center" rowspan="1" colspan="1">PCA dose/route/duration</th><th align="left" rowspan="1" colspan="1">Major finding</th><th align="left" rowspan="1" colspan="1">Interpretation</th><th align="center" rowspan="1" colspan="1">Reference</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Sprague-Dawley rat</td><td align="left" rowspan="1" colspan="1">STZ-induced T1DM (50&#x02009;mg/kg, ip)</td><td align="center" rowspan="1" colspan="1">50, 100&#x02009;mg/kg (po)</td><td align="left" rowspan="1" colspan="1">(i) PCA decreased FBG<break/>(ii) PCA decreased HbA<sub>1c</sub></td><td align="left" rowspan="1" colspan="1">PCA exerted hypoglycemic effects in T1DM</td><td align="center" rowspan="1" colspan="1">[<xref rid="B31" ref-type="bibr">30</xref>]</td></tr><tr><td align="center" colspan="6" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Mice</td><td align="left" rowspan="1" colspan="1">STZ-induced DM (50&#x02009;mg/kg, iv)</td><td align="center" rowspan="1" colspan="1">1%, 2%, and 4% in diet for 8 weeks</td><td align="left" rowspan="1" colspan="1">(i) PCA lowered plasma glucose levels<break/>(ii) PCA increased insulin levels<break/>(iii) PCA decreased TG and TC content in plasma, heart, and liver</td><td align="left" rowspan="1" colspan="1">PCA attenuated diabetic conditions by lowering plasma glucose, increasing insulin, and lowering triglyceride levels</td><td align="center" rowspan="1" colspan="1">[<xref rid="B3" ref-type="bibr">3</xref>]</td></tr><tr><td align="center" colspan="6" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Sprague-Dawley rat</td><td align="left" rowspan="1" colspan="1">STZ-induced DM (40&#x02009;mg/kg, ip)</td><td align="center" rowspan="1" colspan="1">50, 100, 200&#x02009;mg/<break/>kg/day (po) for 45 days</td><td align="left" rowspan="1" colspan="1">(i) PCA decreased plasma glucose levels<break/>(ii) PCA decreased HbA<sub>1c</sub> levels<break/>(iii) PCA increased plasma insulin levels<break/>(iv) PCA increased hexokinase activity and increased glycogen content in liver<break/>(v) PCA decreased activity of glucose 6-phosphatase and fructose 1,6-bisphosphatase in liver<break/>(vi) PCA reduced adipose tissue of DM pancreas and normalized pancreatic islets </td><td align="left" rowspan="1" colspan="1">PCA exerted antihyperglycemic effects by restoring carbohydrate metabolic enzyme activity and increasing plasma insulin levels</td><td align="center" rowspan="1" colspan="1">[<xref rid="B47" ref-type="bibr">46</xref>]</td></tr><tr><td align="center" colspan="6" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Mice</td><td align="left" rowspan="1" colspan="1">STZ-induced DM (50&#x02009;mg/kg, iv)</td><td align="center" rowspan="1" colspan="1">2% and 4% in diet for 12 weeks</td><td align="left" rowspan="1" colspan="1">(i) Content of PCA increased in plasma, brain, heart, liver, and kidney<break/>(ii) PCA decreased water intake and food intake<break/>(iii) PCA increased body weight<break/>(iv) PCA decreased urine volume<break/>(v) PCA reduced plasma glucose levels<break/>(vi) PCA increased plasma insulin levels<break/>(vii) PCA decreased plasma BUN level<break/>(viii) PCA increased creatinine clearance rate <break/>(ix) PCA decreased HbA<sub>1C</sub> level&#x02009;<break/>(x) PCA decreased urine glycated albumin <break/>(xi) PCA reduced renal production of CML, pentosidine, sorbitol, and fructose <break/>(xii) PCA decreased brain content of CML, pentosidine, fructose, and sorbitol<break/>(xiii) PCA decreased urinary albumin <break/>(xiv) PCA reduced level of fibronectin, type-IV collagen, and TGF-<italic>&#x003b2;</italic> in renal tissue&#x02009;<break/>(xv) PCA reduced renal activity and expression of AR and SDH<break/>(xvi) PCA increased renal activity and expression of GLI<break/>(xvii) PCA decreased renal activity and mRNA expression of PKC-<italic>&#x003b1;</italic> and PKC-<italic>&#x003b2;</italic>&#x02009;<break/>(xviii) PCA decreased RAGE mRNA expression</td><td align="left" rowspan="1" colspan="1">PCA had an antihyperglycemic, antiglycative and renoprotective effects via increasing plasma insulin, reducing plasma glucose, reducing renal level of glycation end products, fibronectin, TGF-<italic>&#x003b2;</italic>, and repressing renal activity and expression of AR, SDH, GLI, PKC-<italic>&#x003b1;</italic>, PPAR-<italic>&#x003b3;</italic>, restoring PPAR-<italic>&#x003b3;</italic>, and suppressing RAGE</td><td align="center" rowspan="1" colspan="1">[<xref rid="B16" ref-type="bibr">16</xref>]</td></tr></tbody></table></table-wrap><table-wrap id="tab7" orientation="portrait" position="float"><label>Table 7</label><caption><p>Summary of <italic>in vitro</italic> studies of antiapoptotic activities of PCA in noncancer cells.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Model</th><th align="left" rowspan="1" colspan="1">Model/method</th><th align="center" rowspan="1" colspan="1">PCA concentration</th><th align="left" rowspan="1" colspan="1">Major finding</th><th align="left" rowspan="1" colspan="1">Interpretation</th><th align="center" rowspan="1" colspan="1">Reference</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">HUVECs and Jurkat cells</td><td align="left" rowspan="1" colspan="1">TNF-<italic>&#x003b1;</italic>-induced cell death </td><td align="center" rowspan="1" colspan="1">50, 100&#x02009;<italic>&#x000b5;</italic>M and 1&#x02009;nM</td><td align="left" rowspan="1" colspan="1">(i) PCA inhibited TNF-<italic>&#x003b1;</italic>-induced HUVECs and Jurkat cells death <break/>(ii) PCA increased NF-kB activation<break/>(iii) PCA increased degradation of IkB</td><td align="left" rowspan="1" colspan="1">PCA exerted cell-protective effects via increased IkB degradation and subsequent NF-kB activation</td><td align="center" rowspan="1" colspan="1">[<xref rid="B50" ref-type="bibr">49</xref>]</td></tr><tr><td align="center" colspan="6" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="1" colspan="1">PC12 cells</td><td align="left" rowspan="1" colspan="1">MPP<sup>+</sup>-induced mitochondrial dysfunction and apoptotic cell death </td><td align="center" rowspan="1" colspan="1">0.3, 0.6, and 1.2&#x02009;mM </td><td align="left" rowspan="1" colspan="1">(i) PCA reduced the number of cell death<break/>(ii) PCA at 0.6 and 1.2&#x02009;mM decreased percentage of depolarized cell, reduced ROS formation, and increased GSH content<break/>(iii) PCA at 0.6 and 1.2&#x02009;mM decreased caspase-3 activity and increased Bcl-2 protein </td><td align="left" rowspan="1" colspan="1">PCA exerted antiapoptotic activities via attenuated changes of mitochondrial membrane permeability and decreased oxidative stress damage</td><td align="center" rowspan="1" colspan="1">[<xref rid="B51" ref-type="bibr">50</xref>]</td></tr><tr><td align="center" colspan="6" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Isolated NSCs of embryonic rat</td><td align="left" rowspan="1" colspan="1">Direct PCA application to cells </td><td align="center" rowspan="1" colspan="1">0.006, 0.03, 0.06, and 0.12&#x02009;mM </td><td align="left" rowspan="1" colspan="1">(i) PCA at 0.03, 0.06, and 0.12&#x02009;mM increased cellular viability<break/>(ii) PCA reduced nuclear fragmentation <break/>(iii) PCA reduced the levels of apoptosis<break/>(iv) PCA decreased endogenous ROS level<break/>(v) PCA decreased caspase-3 activity</td><td align="left" rowspan="1" colspan="1">PCA inhibited cell apoptosis via suppression of the caspase cascade</td><td align="center" rowspan="1" colspan="1">[<xref rid="B52" ref-type="bibr">51</xref>]</td></tr><tr><td align="center" colspan="6" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="1" colspan="1">PC12 cells</td><td align="left" rowspan="1" colspan="1">H<sub>2</sub>O<sub>2</sub>-induced apoptosis </td><td align="center" rowspan="1" colspan="1">0.006, 0.03, 0.06, and 0.12&#x02009;mM</td><td align="left" rowspan="1" colspan="1">(i) PCA (over 0.3&#x02009;mM) increased cellular viability <break/>(ii) PCA reduced LDH leakage<break/>(iii) PCA reduced apoptotic sub-G1 population</td><td align="left" rowspan="1" colspan="1">PCA promoted cell viability and inhibited apoptotic cell death</td><td align="center" rowspan="1" colspan="1">[<xref rid="B53" ref-type="bibr">52</xref>]</td></tr><tr><td align="center" colspan="6" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="1" colspan="1">PC12 cells</td><td align="left" rowspan="1" colspan="1">MPP<sup>+</sup>-induced apoptotic cell death</td><td align="center" rowspan="1" colspan="1">0.33, 0.65, and 1.30&#x02009;mM</td><td align="left" rowspan="1" colspan="1">(i) PCA reduced cell death in a dose-dependent manner<break/>(ii) PCA treatment exhibited normal cellular morphology and normal mitochondria<break/>(iii) PCA increased tyrosine hydroxylase expression<break/>(iv) PCA reduced oligomeric <italic>&#x003b1;</italic>-synuclein<break/>(v) PCA increased monomeric <italic>&#x003b1;</italic>-synuclein</td><td align="left" rowspan="1" colspan="1">PCA had neuroprotective effects via reducing cell death and inhibiting oligomerization of <italic>&#x003b1;</italic>-synuclein</td><td align="center" rowspan="1" colspan="1">[<xref rid="B54" ref-type="bibr">53</xref>]</td></tr><tr><td align="center" colspan="6" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Rat primary hepatocytes</td><td align="left" rowspan="1" colspan="1">t-BHP (1.5&#x02009;mM) induced oxidative damage </td><td align="center" rowspan="1" colspan="1">0.02, 0.05, and 0.10&#x02009;mg/mL</td><td align="left" rowspan="1" colspan="1">(i) PCA 0.05 and 0.10&#x02009;mg/mL decreased LDH, ALT, and MDA<break/>(ii) PCA prevented mitochondrial depolarization<break/>(iii) PCA increased scavenging activity on DPPH</td><td align="left" rowspan="1" colspan="1">PCA had a cell-protective effect via its antioxidant and scavenging activity</td><td align="center" rowspan="1" colspan="1">[<xref rid="B55" ref-type="bibr">54</xref>]</td></tr></tbody></table></table-wrap><table-wrap id="tab8" orientation="portrait" position="float"><label>Table 8</label><caption><p>Summary of <italic>in vitro</italic> studies of proapoptotic activity of PCA in cancer cells.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Model</th><th align="left" rowspan="1" colspan="1">Model/method</th><th align="left" rowspan="1" colspan="1">PCA concentration</th><th align="left" rowspan="1" colspan="1">Major finding</th><th align="left" rowspan="1" colspan="1">Interpretation</th><th align="center" rowspan="1" colspan="1">Reference</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">HL-60 leukemia cells</td><td align="left" rowspan="1" colspan="1">Direct PCA application to cells</td><td align="left" rowspan="1" colspan="1">0.2, 0.5, 1, and 2&#x02009;mM</td><td align="left" rowspan="1" colspan="1">(i) PCA increased DNA fragmentation<break/>(ii) PCA declined hyperphosphorylated RB level<break/>(iii) PCA reduced Bcl-2 protein expression <break/>(iv) PCA increased Bax protein expression</td><td align="left" rowspan="1" colspan="1">PCA had an antiproliferative effect via induced RB phosphorylation and degradation and Bcl-2 protein suppression in cancer cells </td><td align="center" rowspan="1" colspan="1">[<xref rid="B56" ref-type="bibr">55</xref>]</td></tr><tr><td align="center" colspan="6" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Human gastric adenocarcinoma (AGS) cells</td><td align="left" rowspan="1" colspan="1">Direct PCA application to cells</td><td align="left" rowspan="1" colspan="1">0.5, 1.0, 2.0, 4.0, 6.0, 8.0, and 9.0&#x02009;mM</td><td align="left" rowspan="1" colspan="1">(i) PCA increased apoptotic bodies formation<break/>(ii) PCA increased p-JNK expression<break/>(iii) PCA increased p-p53 expression<break/>(iv) PCA increased phosphorylation of ATF-2 at Thr<sup>69/71</sup> and c-Jun at Ser<sup>73</sup>&#x02009;<break/>(v) PCA increased Fas expression<break/>(vi) PCA increased FasL expression<break/>(vii) PCA decreased Bcl-2 expression<break/>(viii) PCA increased Bax expression</td><td align="left" rowspan="1" colspan="1">PCA induced apoptosis via JNK/p38 MAPK pathway, activated Fas/FasL pathway, increased translocation of Bax, and reduced Bcl-2 in cancer cells</td><td align="center" rowspan="1" colspan="1">[<xref rid="B57" ref-type="bibr">56</xref>]</td></tr><tr><td align="center" colspan="6" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="1" colspan="1">HepG2 hepatocellular carcinoma cells</td><td align="left" rowspan="1" colspan="1">Direct PCA application to cells</td><td align="left" rowspan="1" colspan="1">0, 3, 10, 30, 100, and 300&#x02009;<italic>&#x003bc;</italic>mol/L</td><td align="left" rowspan="1" colspan="1">(i) PCA decreased viability of HepG2 hepatocellular carcinoma<break/>(ii) PCA increased JNK and p53 expression</td><td align="left" rowspan="1" colspan="1">PCA induced cell death via activating JNK and p38 MAPK pathways in cancer cells</td><td align="center" rowspan="1" colspan="1">[<xref rid="B58" ref-type="bibr">57</xref>]</td></tr><tr><td align="center" colspan="6" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Human breast, lung, liver, cervix, and prostate cancer cells</td><td align="left" rowspan="1" colspan="1">Direct PCA application to cells</td><td align="left" rowspan="1" colspan="1">1, 2, 4, and 8&#x02009;<italic>&#x003bc;</italic>mol/L</td><td align="left" rowspan="1" colspan="1">(i) PCA decreased viability<break/>(ii) PCA enhanced DNA fragmentation<break/>(iii) PCA decreased MMP<break/>(iv) PCA lowered Na<sup>+</sup>-K<sup>+</sup>-ATPase activity<break/>(v) PCA increased caspase-3 activity<break/>(vi) PCA increased caspase-8 activity<break/>(vii) PCA decreased ICAM-1 level<break/>(viii) PCA at 2, 4, and 8&#x02009;<italic>&#x003bc;</italic>mol/L decreased VEGF level<break/>(ix) PCA suppressed IL-6 and IL-8 levels</td><td align="left" rowspan="1" colspan="1">PCA had anticancer properties via increased apoptosis or suppressed invasion and metastasis cancer cells</td><td align="center" rowspan="1" colspan="1">[<xref rid="B59" ref-type="bibr">58</xref>]</td></tr></tbody></table></table-wrap><table-wrap id="tab9" orientation="portrait" position="float"><label>Table 9</label><caption><p>Summary of <italic>in vivo</italic> studies of proapoptotic activity of PCA.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Model</th><th align="left" rowspan="1" colspan="1">Method</th><th align="center" rowspan="1" colspan="1">PCA dose/route/duration</th><th align="left" rowspan="1" colspan="1">Major finding</th><th align="left" rowspan="1" colspan="1">Interpretation</th><th align="center" rowspan="1" colspan="1">Reference</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Rat</td><td align="left" rowspan="1" colspan="1">NMBA-induced esophageal cancer in rats</td><td align="center" rowspan="1" colspan="1">PCA 0.05% in diet for 15, 25, and 35 weeks</td><td align="left" rowspan="1" colspan="1">(i) PCA reduced area of hyperplasia began at week 25 <break/>(ii) PCA reduced COX-2, iNOS, soluble epoxide hydrolase (she), and pentraxin-3 (PTX3) mRNA expression levels</td><td align="left" rowspan="1" colspan="1">PCA prevented esophageal tumorigenesis, by inhibitory effects on genes associated with inflammation</td><td align="center" rowspan="1" colspan="1">[<xref rid="B60" ref-type="bibr">59</xref>]</td></tr></tbody></table></table-wrap><table-wrap id="tab10" orientation="portrait" position="float"><label>Table 10</label><caption><p>Summary of <italic>in vitro</italic> studies of antimicrobial activity of PCA.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Model</th><th align="left" rowspan="1" colspan="1">Method</th><th align="left" rowspan="1" colspan="1">PCA concentration</th><th align="left" rowspan="1" colspan="1">Major finding</th><th align="left" rowspan="1" colspan="1">Interpretation</th><th align="center" rowspan="1" colspan="1">Reference</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">
<italic>Campylobacter spp </italic>
</td><td align="left" rowspan="1" colspan="1">Antimicrobial activity testing</td><td align="left" rowspan="1" colspan="1">(i) 10&#x02009;mg/mL<break/>(ii) 5, 10&#x02009;mg/100&#x02009;g beef</td><td align="left" rowspan="1" colspan="1">(i) PCA inhibited growth and susceptible and antibiotic-resistant <italic>Campylobacter species</italic>&#x02009;<break/>(ii) PCA inhibited growth of aerobes in beef samples<break/>(iii) PCA decreased lipid oxidation levels in ground beef</td><td align="left" rowspan="1" colspan="1">(i) PCA could preserve foods to prevent contamination by <italic>Campylobacter</italic> and aerobes, via decreased lipid oxidation</td><td align="center" rowspan="1" colspan="1">[<xref rid="B63" ref-type="bibr">62</xref>]</td></tr><tr><td align="center" colspan="6" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>Pseudomonas aeruginosa </italic>
</td><td align="left" rowspan="1" colspan="1">Antimicrobial susceptibility testing</td><td align="left" rowspan="1" colspan="1">2,000&#x02009;<italic>&#x003bc;</italic>g/mL</td><td align="left" rowspan="1" colspan="1">(i) PCA inhibited growth of <italic>Pseudomonas&#x02009;&#x02009;aeruginosa</italic>&#x02009;<break/>(ii) PCA plus sulfamethoxazole increased synergistic mode of inhibition of <italic>P</italic>. <italic>aeruginosa </italic></td><td align="left" rowspan="1" colspan="1">(i) PCA had an antibacterial effect by inhibiting bacterial growth and increasing the synergistic effects on antibiotics to reduced drug resistance</td><td align="center" rowspan="1" colspan="1">[<xref rid="B64" ref-type="bibr">63</xref>]</td></tr><tr><td align="center" colspan="6" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Bacteria and fungi</td><td align="left" rowspan="1" colspan="1">Antimicrobial activity testing</td><td align="left" rowspan="1" colspan="1">1.22&#x02013;625&#x02009;<italic>&#x003bc;</italic>g/mL</td><td align="left" rowspan="1" colspan="1">(i) PCA prevented 80% of the growth of organisms</td><td align="left" rowspan="1" colspan="1">(i) PCA had an antimicrobial effect against gram positive and negative bacteria and against fungi </td><td align="center" rowspan="1" colspan="1">[<xref rid="B61" ref-type="bibr">60</xref>]</td></tr><tr><td align="center" colspan="6" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>Helicobacter pylori </italic>
</td><td align="left" rowspan="1" colspan="1">Antimicrobial susceptibility testing</td><td align="left" rowspan="1" colspan="1">8&#x02013;64&#x02009;mg/L</td><td align="left" rowspan="1" colspan="1">(i) PCA inhibited growth of <italic>H</italic>. <italic>pylori</italic>&#x02009;<break/>(ii) PCA reduced drug-resistant <italic>H</italic>. <italic>pylori</italic>&#x02009;<break/>(iii) PCA at (32&#x02013;40&#x02009;mg/L) reduced urease activity of <italic>H</italic>. <italic>pylori</italic> to 40%</td><td align="left" rowspan="1" colspan="1">(i) PCA had growth prevention effects on <italic>H</italic>. <italic>pylori </italic></td><td align="center" rowspan="1" colspan="1">[<xref rid="B62" ref-type="bibr">61</xref>]</td></tr></tbody></table></table-wrap></floats-group></article>